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ABSTRACT 
 
 Influenza virus is a negative sense, single stranded RNA virus that can cause severe 
respiratory tract infections in humans (along with other host animals such as horses, swine and 
poultry). Certain populations such as very young children, aged individuals, pregnant women 
and immunosuppressed individuals are more susceptible to influenza infections. One reason for 
the increased susceptibility to infection in the aged is a decreased efficacy of the seasonal 
influenza vaccine. As this particular section of our population continues to increase worldwide, 
research to improve vaccine efficacy is expanding along with efforts to identify lifestyle changes 
and interventions that can improve the immune response to vaccination. For these purposes, it is 
important to understand the mechanism by which age affects the immune response. Multiple age-
related defects in T-cell or B-cell response to influenza infection have been well documented, but 
the impact of age on innate host defense to influenza is not well-characterized. Defects of the 
early innate host antiviral pathways have not been studied in depth and could impact early host 
defense as well as appropriate activation of adaptive immunity. The aim of the study conducted 
in chapter 2 was to identify age-associated alterations of innate recognition/response to influenza 
virus. The results identified an impairment of innate defense proteins and Toll Like Receptor 
signaling molecules in lungs of healthy old mice compared to young mice. The study also 
confirmed the presence of a chronic low level inflammation in the lungs usually systemically 
associated with aging.  Mice infected with influenza virus elicited an impaired and possibly 
delayed anti-viral response to the virus.  
 It has been suggested that exercise can modulate the immune response to various 
respiratory pathogens. Physical activity may be beneficial for the immune response to pathogens 
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and infections in aged immune systems by decreasing morbidity and mortality. In chapter 3, we 
studied the potential impact of exercise on innate immune pathogen recognition and anti-viral 
responses. We used a model of chronic, regular moderate exercise in comparison to no exercise 
to assess alterations in the immune response to influenza virus infection. An exercise-associated 
reduction of lung viral load was observed in aged exercised-treated mice that were infected with 
influenza virus as compared to aged non-exercised mice. The results from this chapter indicated 
that early host innate defenses were altered by exercise training and may lead to the decreased 
viral load early during the course of influenza infection.  
   In chapter 4, the acute effects of a single session of exercise were studied in lungs of 
young mice. This was done in order to identify an effect of exercise on the activation of stress or 
host defense pathways given that the response of lung tissue to exercise is not well known, as 
compared to the effect of exercise on other tissues such as cardiac or skeletal muscle. Activation 
of stress response or altered cellular defense pathways and immune cell populations could affect 
the lung response to a pathogen such as influenza virus. In our results we discovered that acute 
exercise resulted in heat shock protein response as well as activation of several genes associated 
with regulation of inflammation. The effects of chronic exercise on the same stress response was 
also studied, resulting in a down-regulation of heat shock proteins, and no change in  expression 
of genes associated with apoptosis or inflammation. Exercise training may cause a shift of CD45 
positive leukocytes from the BAL into the lungs as the CD45+ population decreased in the BAL, 
but increased in the lung. Taken together, these changes suggest that exercise training may 
promote an anti-inflammatory environment in the lung. We speculate that exercise training may 
cause the lung tissue to adapt to stress and downregulate the heat shock response and any 
inflammation caused due to exercise. A shift in immune cells from BALF to lungs may explain 
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our previous findings of reduced viral titer and decreased inflammation with influenza infection 
in exercise trained mice.  
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CHAPTER 1 
GENERAL INTRODUCTION 
 
Introduction to the dissertation 
Organization of the Dissertation 
This dissertation contains the experimental data and results obtained by the author during 
her Ph.D. study under the supervision of her major professor Dr. Marian L. Kohut at Iowa State 
University, Immunobiology Interdepartmental Program.  
The document contains manuscripts that are being prepared for submission to peer-
reviewed journals. The dissertation contains a total of five chapters including a general 
introduction, three research papers, and a general conclusion that discusses the overall findings 
from the dissertation, followed by acknowledgements. The figures are provided directly 
following each chapter, followed by the references.  
The General Introduction (Chapter I) to the dissertation begins with briefly the 
background information on the lifecycle of influenza A viruses and the host immune response to 
the virus. This is followed by the current status of knowledge and literature review on aging 
immunology research and exercise immunology. Chapter 2 focuses primarily on aging and the 
innate immune response, while chapters 3 and 4 focus on exercise immunology in the old and the 
young respectively. This is followed by the conclusions and summary of the findings of the 
dissertation, presented in chapter 5. The references that are used in the Introduction and literature 
review are provided, followed by the acknowledgements at the end.  
Influenza virus Infection 
The influenza virus is part of the Orthomyxoviridae family of viruses. These are negative 
sense, single stranded RNA viruses and include the thogotovirus and isavirus, along with the 
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three genera of influenza viruses, types A, B and C. Influenza A viruses are the causative agent 
of most severe respiratory tract infections. The symptoms of influenza viral infection may 
include fever, chills, cough, sore throat, runny or stuffy nose, pronounced fatigue, and less often 
nausea, vomiting and/or diarrhea. Some infected people may have no symptoms but may shed 
virus for up to a week.  Severe cases of infection may require hospitalization and can be fatal, 
primarily because of damage caused by the immune response in the lung microenvironment. 
Influenza B viruses cause the same spectrum of disease as influenza A. However, influenza B 
viruses do not cause pandemics, possibly because of the limited hosts (humans and seals). 
Influenza C virus causes mild upper respiratory tract illness, and nearly all adults have been 
infected with influenza C virus (217).  
 Vaccines for influenza infection are available and contain two strains of Influenza A and 
one Influenza B strain. There are two types of influenza vaccine – the trivalent inactivated 
vaccine containing killed virus, and the live, attenuated intranasal influenza vaccine. Because of 
the high rate of mutation of the virus, the strains used in the vaccine are changed every year, 
based on  
to the World Health Organization’s prediction for the year’s prevalent strains. For example, the 
vaccine for the 2012-13 influenza season contain an A/California/7/2009 (H1N1)-like virus; an 
A/Victoria /361/2011 (H3N2)-like virus; a B/Wisconsin /1/2010-like virus (52).  
Structure of Influenza A virus 
The influenza virion is a roughly spherical, enveloped virus with glycoprotein spikes 
embedded into the lipid membrane, known as HA (hemagglutinin) and NA (neuraminidase) in a 
ratio of approximately four to one. These proteins determine the subtype of influenza virus (168). 
There are currently 16 known HA subtypes (56) and 9 NA subtypes. Also embedded in the lipid 
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membrane is the M2 protein, with an M2: HA ratio of one M2 channel per 101-102 HA 
molecules (247). Beneath the lipid membrane is a viral protein called M1, or matrix protein.  The 
genome of the influenza A virus contains segmented, single-stranded RNA of negative polarity.  
The eight RNA segments code for the viral proteins PB1, PB2, PA, HA, NA and NP proteins 
(168). The interior of the virion also contains another protein called NS2 or NEP (viral nuclear 
export protein). The single stranded RNAs are associated with multiple monomers of 
nucleoprotein (NP) and a single copy of the polymerase which is a heterotrimer composed of the 
PB1, PB2 and PA subunits. This whole unit is called a ribonucleoprotein (RNP) particle. Such 
RNPs are independent molecular machines responsible for transcription and replication of each 
virus gene. The M1 protein forms a layer to separate the RNP (Ribonucleoprotein) from the viral 
membrane (168). This protein, which forms a shell, gives strength and rigidity to the lipid 
envelope and may be required for viral budding (72), though some studies have shown otherwise 
(27). The M2 protein is the target of the antiviral adamantanes – amantadine and rimantadine. 
The NA protein is the target of the antiviral drugs zanamivir (brand name Relenza) and 
oseltamivir (brand name Tamiflu) (206). 
Life Cycle of influenza A virus   
Influenza Virus Attachment to Cells: 
Influenza viruses recognize N-acetylneuraminic (sialic) acid on the host cell surface. The 
HA spikes on the surface of influenza virus recognize and bind to sialic acid moieties on the cell 
surface. The virus HA have a preferential specificity for either α (2,3) or α (2,6) linkages (168). 
This preference is governed by amino acid sequence in the pocket region of the HA molecule 
(231). In human tracheal epithelial cells, α (2,6) linkages predominate, while α (2,3) linkages are 
more common in duck gut epithelium. Epithelial cells of the pig trachea produce both α (2,3) and 
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α (2,6) linked sialic acids. This is believed to be the reason pigs can be infected with both avian 
and human influenza virus strains and serve as a ‘mixing vessel’ for the emergence of new 
viruses (168). 
Influenza Virus Entry:  
After the virion attaches to sialic-acid containing receptors at the cell surface, the virus-
receptor complex is taken into cells by endocytosis, more specifically clathrin-mediated 
endocytic pathway. This form of entry is characterized first by the congregation of several HA 
proteins interacting with glycoproteins, followed by the formation of clathrin-coated pits. Some 
studies have also suggested other (clathrin independent) routes of entry such as caveolin-
dependent and -independent endocytosis (163, 198). It is common in all modes of entry for the 
virus to be internalized within a vesicle that eventually uncoats and fuses with another more 
acidic vesicle forming an endosomal compartment (121). The pH in the endosome drops and this 
triggers a conformational change in the HA, exposing a fusion peptide. This peptide functions to 
merge the viral envelope with the endosomal membrane, thus creating an open pore for the 
release of viral RNPs into the cytoplasm of the host cell. Simultaneously, the M2 ion channel 
transports hydrogen ions from the endosome into the virus particle. This causes internal 
acidification of the influenza virion and disrupts internal protein-protein interactions, allowing 
viral RNPs to be released from the viral matrix into the cellular cytoplasm (192). 
Influenza Virus Replication: 
The RNPs are transported to the host cell nucleus through nuclear pores via viral 
proteins’ nuclear localization signals (NLSs). Influenza virus requires the use of the nuclear 
machinery of the host for replication to occur. Replication and transcription of viral RNA is 
thought to occur simultaneously within the host nucleus (91). The viral RNA dependent RNA 
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polymerase synthesizes two kinds of positive strand RNA from the viral negative sense RNA – a 
viral mRNA template for viral protein synthesis (using the host’s translation machinery) and a 
cRNA or complimentary RNA intermediate which will eventually form viral RNA for progeny 
viruses.  
A process called cap snatching initiates the transcription process of influenza viral RNA 
(175). In this process, PB2 binds to the cap of host mRNA (53, 79) and an endonuclease encoded 
by the PA subunit cleaves the host mRNA after the first 10 to 13 nucleotides (40). This fragment 
is used as a primer for transcription. Transcription is terminated when a string of 5 – 7 uridines 
(U-track) are encountered and a polyadenylated (poly-A) tail is added to the viral mRNA (178). 
The newly synthesized viral mRNA is exported from the nucleus into the cytosol by the M1 and 
NEP proteins (32).  
Replication of the viral RNA to form cRNA does not involve cap snatching or a poly-A 
tail addition and is a primer-independent process. Replication is carried out by the same 
polymerase heterotrimer and the resulting cRNA are full-length copies of the viral RNA 
segments, associated with NP protein. The mechanism for the regulation of replication is not yet 
completely understood (28).  
Viral proteins are thought to be synthesized in an early phase and late phase, 
corresponding to two phases of mRNA synthesis (193).  During the early or first phase of protein 
production, all eight genome segments are transcribed in equal amounts by the host cells leading 
to an equal level of production of all of the viral proteins encoded in those segments. During the 
early second phase of transcription the NS1 and NP proteins are selectively produced, followed 
by a late phase in which NS1 production is reduced while HA, NA and M1 proteins begin to be 
up-regulated. The M1 and NEP proteins are associated with translocation of vRNPs and 
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packaging of the viral components into a newly synthesized virion. Membrane bound proteins 
such as HA, NA and M2 are transported to the cell surface after post-translational modifications.  
Influenza Virus Release:  
Influenza virus utilizes lipid raft domains in the plasma membrane of infected cells as 
sites of virus assembly and budding. The HA and NA proteins assemble at the lipid rafts, and the 
difference in protein concentrations in the lipid raft induces a curvature on the outside of the host 
cell leading to bud formation and subsequently the release of a newly formed virion from the cell 
surface (185). Viral HA is cleaved into two proteins called HA1 and HA2 after the newly 
synthesized virions are released from cells. The protease required to cleave the HA protein is 
present in the human respiratory tract and restricts the replication of influenza virus to that 
location.  
Antigenic Drift and antigenic shift 
Antigenic drift is the gradual evolution of viral strains due to frequent subtle mutations 
involving point mutations within antibody-binding sites in the HA protein, the NA protein or 
both. Most of these mutations do not affect protein conformation but some mutations cause 
changes to the viral proteins, altering the binding to host antibodies. Consequently, infectious 
viruses can no longer be inhibited effectively by host antibodies raised to previously circulating 
strains, allowing the virus to spread more rapidly among the population.  
Antigenic shift occurs when two different strains of virus infect one host animal. It is 
possible that when the cell is infected with both strains, the progeny virus may inherit RNA from 
both parent strains and would be called a reassortant. This progeny virus would display surface 
proteins from both strains and the resulting strain could be completely novel for some host 
populations, resulting in high infectivity and/or pandemics. Antigenic shift is only seen in 
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influenza A viruses, and usually results from the replacement of HA, and less frequently NA 
subtypes with novel ones. Because of antigenic drift and seasonal variability, it is important to 
monitor the circulating strain of influenza and develop vaccinations to those strains in a timely 
manner. Monitoring the circulating strains also helps in screening for viral reassortment due to 
antigenic shift (23, 225). 
Immune Response to Influenza Infection 
The epithelial cells of the lung act as a physical and immunological barrier to infection. 
The alveolar epithelium consists of two main populations: alveolar type I (ATI) and type II 
(ATII) epithelial cells. The ATI cells constitute roughly 10% of the alveolar population and are 
responsible for most of the gas exchange in the alveoli. The ATII population provides 
approximately 5% of the alveolar surface and provides protection for the alveoli and act as stem 
cells for ATII and ATI cells. Other cell types present are the surfactant producing Clara cells, 
mucus producing goblet cells, sensory neuro-epithelial cells, and basal cells that act as 
progenitors for other select cell types (190). The airway surface liquid interface consists of two 
layers, a mucus layer and a periciliary liquid layer, also sometimes referred to as “sol” layer. The 
mucus layer is a network of polymers that consists of high molecular weight, heavily 
glycosylated macromolecules, products of at least two distinct genes (MUC5AC and MUC5B). 
The liquid layer is a low-viscosity solution in which cilia can beat rapidly and protects the 
epithelial cell surface from the overlying viscous mucus layer (110).The cilia of the respiratory 
epithelium beat in concert creating the mucociliary escalator. This system effectively moves 
secreted mucus containing trapped foreign particles toward the laryngopharynx, for either 
expectoration or swallowing to the stomach where the acidic pH helps to neutralize foreign 
material and micro-organisms.  
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 The air liquid interface also contains many proteins, some of them anti-microbial 
peptides such as defensins, lactoferrin, and lysozyme. The airway epithelial cells contain certain 
Pattern Recognition Receptors (PRRs) that recognize conserved sequences of pathogens, which 
are called Pathogen Associated Molecular Patterns (PAMPs). The main cell-associated PRRs 
activated by influenza infection are Toll-like Receptors (TLRs), NOD-like receptors, RIG-I and 
MDA-5 (230). Some fluid-phase molecules such as collectins and pentraxins also act as PRRs 
associated with the respiratory system.  
Defensins: 
Defensins are small cationic microbicidal substances secreted into the epithelial lining 
fluid by neutrophils and Paneth cells (α-defensins), or keratinocytes and epithelial cells (β-
defensins). They act as chemokines to recruit dendritic cells and T cells. There are 10 known 
human defensins: six α-defensins (HADs) and four β-defensins (HBDs). HADs have 
inflammatory properties such as inducing the release of histamine, chemokine induction through 
NF-κB binding, and direct toxicity to alveolar epithelial cells. HBDs are thought to have mainly 
microbicidal function, although they recruit dendritic cells and memory T cells through 
interaction with cc chemokine receptor-6 (246).  
Collectins: 
Collectins, or collagen-binding lectins, are members of the C-type lectin superfamily, 
mainly SP-A, SP-D, and MBL. SP-A is produced by alveolar type II cells and Clara cells within 
the alveolar epithelium. SP-A binds to organisms that enter the pulmonary tree and either 
enhances their phagocytosis by alveolar macrophages or enhances their permeability. SP-A is a 
Ca+2 independent γ inhibitor, binding to viral HA through the sialic acid residues present on the 
SP-A molecule, blocking the receptor binding site on the virus. SP-D modulates cytokine 
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production and inflammatory responses, enhances opsonization and clearance of virus during 
viral infection. SP-D is a classic β inhibitor, agglutinating influenza A virus and neutralizing the 
virus by attaching to oligosaccharides on the viral envelope proteins (HA and NA) through its 
lectin domains in a Ca+2 dependent manner (132). Because of this property, the less 
glycosylated influenza viruses, such as the H1N1 virus used in our study (A/PR/8/34 H1N1) are 
less susceptible to inhibition by SP-D (84). MBL is the third major member of the pulmonary 
collectins, and functions by activating the complement system through C3b. MBL binds to the 
receptor calreticulin leading to an increase in monocyte activity, stimulation of the oxidative 
burst, and enhanced endothelial phagocytosis of pathogens (227).  
Pentraxins: 
Pentraxin 3 (PTX3), a long pentraxin, is constitutively stored in neutrophil granules and 
also induced in response to TNF-α and TLR agonists such as LPS. PTX3 can interact with a 
number of pathogens, including some strains of influenza virus, modulate the complement 
activity by binding C1q and can amplify the inflammatory response (151). Human and murine 
PTX3 bind to influenza virus and act as a γ inhibitor, binding to viral HA through sialylated 
ligands on its surface. PTX3 also binds to infected cells, potentially leading to destruction before 
release of virions. A study has shown that absence of PTX3 aggravates infection and treatment 
with PTX3 reduces the viral load (181). However, it was recently reported that H1N1 influenza 
A virus (including A/PR/8/34) were resistant to antiviral activity of PTX3, though it is produced 
and expressed upon viral infection regardless of strain resistance or susceptibility (103). 
Pathogen Recognition Receptors (PRR):  
RIG-I and MDA-5: 
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Retinoic acid–inducible gene I (RIG-I) is a cytoplasmic protein that was identified as 
participating in the recognition of virus nucleic acid inside the cell (126, 245). It recognizes the 
5’ phosphorylated end of uncapped viral RNA and thus has the capability of discriminating 
between self and non-self RNA (93, 173). RIG-I has a helicase domain that is required for 
interaction with dsRNA. It contains two caspase-recruiting domains (CARD) at the N-terminus 
that interact with other CARD-containing adaptor proteins and are responsible for activating 
downstream signaling leading to IRF3 and NF- B. The C-terminal region contains a repressor 
domain which inhibits downstream signaling (187).   
 Melanoma differentiation-associated gene 5 (MDA-5; also called Helicard) is structurally 
related to RIG-I in that it also contains two CARD-like regions, a helicase domain, and a C-
terminal region similar to the repressor domain of RIG-I. MDA-5 is also involved in viral 
recognition (105, 203).  The CARD domains on RIG-I and MDA-5 recruit a mitochondria-
associated protein called IPS-1 (also called MAVS, Cardif or VISA). This leads to activation of 
NFκB, IRF3 and IRF7, and consequently inflammatory cytokines and type I IFNs (106, 107).  
Toll-like Receptors: 
Toll-like receptors (TLRs) comprise a family of proteins that recognize pathogen-
associated molecular patterns (PAMPs) and initiates host innate immune responses. TLRs 
contain extracellular leucine-rich repeats that recognize and bind to their respective PAMPs, a 
transmembrane domain, and an intracellular domain similar to that of IL-1 receptor known as the 
Toll/IL-1 receptor (TIR) domain. The intracellular domains interact with adaptor proteins and 
activate downstream signaling pathways. Currently, the TLR family consists of more than 13 
members in mammals, each detecting different PAMPs. 10 TLRs have been identified in humans 
and 12 in mice. They are constitutively present on many nucleated cells and can be up-regulated 
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in response to pathogens and/or cytokines (164). TLR3, TLR7, TLR8 and TLR9 recognize viral 
genomic material. TLR3, TLR7 and TLR9 are mainly present on Endoplasmic Reticulum (ER) 
membrane and are recruited to endolysosomes upon stimulation by their ligands. TLR3 
recognizes double stranded RNA in the endolysosome, TLR7 and TLR8 recognize uridine rich 
sequences of single stranded RNA(139), and TLR 9 senses unmethylated DNA with CpG motifs. 
TLR7 and TLR9 are highly expressed on plasmacytoid dendritic cells (pDC), which produce 
large quantities of type I Interferons (IFN). TLR3 is expressed by conventional dendritic cells 
(cDCs) and macrophages as well as non-immune cells including fibroblasts and epithelial cells. 
TLR3 is localized on intracellular vesicles in cDCs, while it is localized to the cell surface as 
well as intracellular vesicles in fibroblasts and epithelial cells.  
 All TLRs (except TLR3) signal through MyD88 which activates other signaling proteins 
that ultimately phosphorylate an NF-κB inhibitory protein. This frees the NF-κB to translocate to 
the nucleus and activate expression of pro-inflammatory cytokine genes. The MyD88 pathway 
also activates the MAP kinase cascade, which leads to formation of transcription factor complex 
AP-1 that also targets cytokine genes. TLR7 and TLR9 are selectively expressed by pDCs. They 
signal via the MyD88 protein and this leads to phosphorylation of IRF7, which translocates to 
the nucleus and activates genes encoding type I IFNs (89, 94). In cDCs, IRF1 is activated 
resulting in IFN-β gene expression. 
 TLR3 recruits an adapter protein, TRIF, and activates IRF3, and NFκB. IRF7 is also 
activated via the TBK1 and IKKi complex. IRF3 is involved in IFNβ and IFNα4 induction. 
These subtypes of interferon signal via the type I interferon receptor and activate a 
transcriptional complex known as ISGF3 which consists of transcriptional activators STAT1 and 
STAT2, and IRF9. This pathway results in the expression of the IFN inducible genes or IFN 
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stimulated genes (ISGs) such as IRF7, Protein Kinase R and others, required for antiviral 
responses. TBK1 and IKKi phosphorylate IRF7 in a manner similar to IRF3, inducing type I 
IFNs as well. 
Type I IFN response to influenza virus: 
Interferons are cytokines secreted by host cells in response to viral pathogens including 
influenza virus. They are mainly classified into three types - Interferon type I, II and III. Type I 
IFNs bind to a specific cell surface receptor complex known as the IFNα receptor (IFNAR) that 
consists of IFNAR1 and IFNAR2 chains. The type I interferons present in humans are IFNα 
which has 13 subtypes, IFNβ and IFNω. Interferon type II, IFNγ which has 3 subtypes binds to 
IFN-γ receptor (IFNGR) that consists of IFNGR1 and IFNGR2 chains. Type III Interferons were 
recently recognized as IFNλ (or IL28/29) and binds to IFNλ receptor(IFNLR) consisting of 
IFNLR1 and IL10R2 chains (10).  
 As described above, PRRs activate downstream pathways that stimulate type I IFN (IFNα 
and IFNβ) production. In response to influenza virus, type I IFNs are secreted from pDCs, 
alveolar macrophages, and infected epithelial cells (99) although recent studies show that ATII 
cells do not produce IFNα but do produce IFNβ and IFNλ (233). Type I IFNs up-regulate the 
transcription of many IFN-inducible genes or IFN stimulated genes (ISGs). ISGs include 
transcription factors like IRF3 and STAT1/2 enabling an amplification loop. Other ISGs are 
proteins that influence protein synthesis, growth arrest, and apoptosis to create an antiviral state 
(67). Type I IFNs also function to enhance dendritic cell (DC) maturation, natural killer (NK) 
cell activation, antibody production, and differentiation of virus-specific cytotoxic T 
lymphocytes (CTL). The IFN type I receptor is expressed by the infected IFN-producing cells as 
well as on uninfected neighboring cells, rendering an anti-viral state. The receptor activates the 
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JAK/STAT pathway which in turn induces the transcription of several ISGs, some of which are 
discussed below.  
Mx:  
 The orthomyxovirus resistance gene or Mx was the first ISG found to restrict influenza 
virus replication (80). Mx can be induced by type I IFNα/β and type III IFNλ. Both mouse Mx1 
and the human homologue MxA inhibit influenza virus replication (77, 209). MxA in humans 
has shown anti-viral properties against both nuclear and cytoplasmic viruses. MxA is a GTPase 
expressed by various cell types in peripheral tissue, for example hepatocytes, endothelial cells, 
peripheral blood mononuclear cells (PBMCs), pDCs and myeloid cells. MxA has a central 
interacting domain and a leucine zipper at the C terminal which recognizes viral nucleocapsid-
like structures. It functions by oligomerizing around the ribonucleocapsids to form rings around 
the viral RNA and blocking viral replication (232). Most of the laboratory strains of mice lack a 
functional Mx1 and therefore are highly susceptible to influenza virus infection (208). 
Protein Kinase R (PKR): 
 PKR is an IFN inducible protein kinase that becomes activated upon binding to dsRNA. 
Most of the antiviral activity of PKR is due to phosphorylation of eiF2α, which results in a 
general translational block, limiting viral replication (174).  
Oligoadenylate synthetase (OAS): 
 OAS is the first component of the OAS/RNAseL antiviral system. Similar to PKR, OAS 
is IFN inducible but requires binding to dsRNA for activation of its enzymatic activity. Once 
activated, OAS generates 2′–5′ oligoadenylates that act as a co-factor for a latent cytoplasmic 
RNAse, RNAse L. Activated RNAse L cleaves viral and cellular RNA stopping viral replication 
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(26). In addition, it has also been shown that the cleaved products of RNAse L can activate RIG-
I, and therefore serve as a positive feed-back to enhance IFN production (140).  
IFN stimulated gene 15 (ISG15): 
ISG15 is a 15kDa homolog of ubiquitin. While the mechanism is still unclear, it is 
thought that ISGylation does not cause degradation, but has an activating effect on its target 
proteins, such as JAK1, STAT1, RIG-I, MxA, PKR or RNase L. For example, ISG15 prevents 
virus mediated degradation of IRF3. It may also have extracellular functions as a cytokine to 
modulate the immune response (131, 248).  
Viperin: 
 Viperin is an IFN inducible protein that localizes in the ER, where it was found to 
interact with and inhibit farnesyl diphosphate synthase, an enzyme required for isoprenoid 
biosynthesis. This inhibition leads to changes in membrane fluidity and membrane 
microdomains, which in turn affect the ability of influenza virus to efficiently bud from infected 
cells, then restricting viral replication (235).  
Tetherin or BST2: 
 Tetherin (also known as BST2) also restricts viral budding, by retaining newly assembled 
virions attached to the plasma membrane (127).  
IFN inducible transmembrane proteins (IFITMs): 
 In contrast to the budding inhibitors viperin and tetherin, IFITMs are interferon inducible 
genes that restrict viral entry (19), possibly through the fusion activity of the HA protein which is 
essential for entry (134).  
dsRNA specific adenosine deaminase (ADAR1): 
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 ADAR1 is another ISG that has anti-viral activity. It is a site specific protein that 
converts the adenosine in RNA to inosine, destabilizing the dsRNA (224).  
Recruitment of immune cells during influenza infection 
Innate cells are recruited to the lungs in response to chemokines, and are necessary to 
control the early replication and spread of influenza A virus infection in the lungs. Alveolar 
macrophages are the primary phagocytes found in the alveoli and can be infected by influenza 
virus. Viral infection activates the cells and converts them into highly phagocytic cells that 
produce inflammatory cytokines, including IL-6 and TNFα (234). Inflammatory monocytes are 
recuited to the lungs via CCL2, which then differentiate into monocyte derived dendritic cells 
(DC) and inflammatory macrophages. NK cells are recruited to the site of viral infection via 
MIP-1α and MIP-1β and produce large amounts of cytokines such as IFNγ, TNFα, and MIP-1α. 
NK cells can recognize hemagglutinin protein of the influenza virus via the NKp46 molecule 
(141). They interact with influenza infected DCs via theNKG2D and NKp46 receptors (44), and 
this interaction along with IL12 leads to activation and increased IFNγ production of NK cells. 
NK cells have potent cytotoxic activity that is dependent on IFNα/β (183). IL12-activated NK 
cells have the ability to activate DC by inducing maturation and via IFNα and TNF production 
(69). Neutrophils will also migrate to the site of infection, may inhibit viral replication, and 
engulf cells opsonized with antibody or even with lectins (64, 83). Once these cells are engulfed 
by the neutrophil, the neutrophil may carry out a granulocytic, anti-microbial activity leading to 
further containment of the virus (216).  
 DCs play a major role in bridging the adaptive and innate immune response to influenza. 
DCs are located throughout the respiratory tract and constantly survey for invading pathogens or 
foreign material. pDCs are recruited into the lung via the chemoattractant properties of CXCL10 
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(31) and produce massive amounts of IFNα (75), discussed in previous sections of this review.  
The cDC also resides in the lung in an immature state, and will migrate into the lung 
environment in response to CXCL12 after infection occurs (31). Once cDCs have sensed a 
pathogen (via PRRs), they will uptake that antigen, process it and begin to migrate towards a 
draining lymph node, and simultaneously take on a mature phenotype.  This mature phenotype is 
characterized by the increased expression of MHC-class I and II molecules, and the co-
stimulatory molecules CD80 and CD86 which are necessary for the activation of the adaptive 
immune response.  
The autophagy pathway 
This is a highly conserved cellular pathway that is used by the cell to degrade cytosolic 
organelles and proteins. Macroautophagy, the most studied pathway of autophagy involves 
formation of an autophagosome, a double membrane structure, around cytosolic contents. The 
autophagosome fuses with a lysosome to form the autolysosome that degrades the targeted 
proteins or organelles. The primary function of this pathway is to recycle the nutrients and 
energy within the cell. It also prevents the accumulation of and the resulting damage caused by 
aggregated proteins, and is speculated to improve genetic stability and mitochondrial quality 
control.  
Autophagy has been shown to mediate the delivery of antigens and enhance antigen 
presentation as demonstrated by enhancement of BCG vaccine antigen presentation by APCs. 
MHC II antigen presentation was enhanced, improving Th1 mediated protection (97). It is also 
involved in the processing of endogenous antigens such as Epstein Barr viral antigens and 
selective targeting of influenza matrix protein and delivery to MHC II molecules. 
Autophagosome formation occurs constitutively in pDCs and pDCs derived from Atg5-deficient 
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mice failed to produce IFNα after VSV infection (129). Autophagy may also contribute to innate 
immunity by reducing inflammation via decreasing necrosis and apoptosis, and inhibiting pro-
inflammatory signaling via RIG-I like receptors and induction of inflammasomes (133, 186, 
241). Several immune mediators such as PKR, CD40-CD40L interactions, IFNγ, TNFα, TLR4 
and Th1 cells have the ability to stimulate autophagy (133). Studies have been conflicting on 
whether the proteins involved with autophagy are anti-viral (133, 213) or support viral 
replication (241). 
Therefore, this process is up-regulated by infections and anti-viral responses and serves 
to facilitate antigen presentation and recognition by the cells and molecules of the immune 
response. It may also act to control some of the excessive or harmful effects of a robust response 
by reducing inflammation. Although the precise functions of this pathway are not yet completely 
understood, it is clear that it plays a role in the immune response to viral infections.  
Adaptive immune response to influenza infection 
The adaptive or acquired immune response consists of the humoral response (consisting 
mainly of antibodies) and the cell mediated response (via lymphocytes). Important characteristics 
of the adaptive immune response are the ability of the adaptive system to differentiate between 
‘self’ and ‘non-self’, and generate a specific response to a given pathogen. The cells of the 
acquired immune system are T and B lymphocytes. B cells produce antibodies and play a large 
role in the humoral immune response, whereas T cells are involved in cell-mediated immune 
responses.  
 Extensive communication between the innate and adaptive systems is carried out with the 
help of cytokines that bind to cells, and via cell- cell interactions for example between DC and 
lymphocytes. Antigen presenting cells (APCs) such as cDC’s acquire cytosolic viral antigens 
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through the MHC I molecule, and extracellular viral antigen through phagocytosis (also called 
cross presentation). The extracellular antigens are presented on MHC II molecules in a process 
called antigen presentation. Upon stimulation with microbial products, inflammatory cytokines 
or CD40 ligation, DCs start to mature and migrate to the draining lymph nodes. Maturation of 
DCs is associated with phenotypic changes including down-regulation of phagocytic capacity, 
up-regulation of costimulatory molecules, MHC and secretion of cytokines. This process 
transforms them into fully functional APCs capable of priming naïve T cells through 
presentation of antigen on MHC molecules.  
The MHC I and MHC II molecules are recognized by the receptors on CD8+ T cells and 
CD4+ T helper (Th) cells respectively. Recognition of antigens presented on MHC I of APCs by 
the T cell receptor, a second signal via costimulatory molecule CD80/86 on APCs interacting 
with CD28 on naïve T cells and cytokines such as IL2 are required to activate the T cell. The 
naïve CD8+ T cells that recognize influenza antigen and express CD28 then begin the process of 
clonal expansion. The effector CD8+ T cells or cytotoxic T lymphocytes (CTLs) return to the 
lung in a phenomenon called cellular homing, possibly via CD27 (90). They recognize influenza 
infected cells via their T cell receptor and kill those cells by producing IFNγ (type II IFN) and 
directed release of perforin and granzymes. IL-12 secreted by cDCs is essential for CTLs to 
produce IFNγ which activates other immune cells (for example increases phagocytic activity by 
macrophages) and drives activated B cells to produce highly specific anti-influenza antibody.  
CTLs serve a cytotoxic function by producing perforin and granzymes specifically in response to 
influenza virus infected cells which express the influenza peptides and MHC I complex on their 
surface. The CTLs do require the help of Th cells, as reviewed next. 
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 Naïve CD4+ T cells are activated in a similar way by T cell receptor ligation to antigen 
presented on MHC II of APCs and costimulation. However, they are not involved in cytolytic 
killing but play a vital role in activation of influenza-specific B cells. Until recently, it was 
thought that two types of effector CD4+ Th cell responses can be induced by a professional 
APC, designated Th1 and Th2. However, recently many other subsets of Th cells have been 
discovered. Th cell subset development is dependent on the cytokines that the cell is exposed to 
and the transcription factors that are expressed in the cell. Each subset produces a different set of 
cytokines and have various functions in the body. For example, IL12(p70) and IL18 polarizes the 
Th cell response towards T-bet expressing, IFN-γ and TNF secreting Th1 cells which have the 
ability to activate macrophages against intracellular pathogens. Similarly IL4, IL25, IL33 and 
thymic stromal lymphopoietin (TSLP) induce differentiation towards Th2 cells which express 
transcription factor GATA3 and produce mainly IL4, IL5, IL6 and IL10. Th2 cells activate B 
cells and mediate humoral immunity to extracellular parasites. Regulatory T cells (Tregs) are 
generated by stimulation with TGF-b in the absence of IL-6. More Th subsets have been 
discovered such as IL17-secreting Th17 cells, IL22-secreting Th22 cells, IL9-secreting Th9 cells 
and T follicular helper cells (Tfh) which can prime B cell antibody responses. Furthermore, 
studies have shown that Th cell lineages are not irreversible, but tend to be more changeable than 
previously believed (249). Generally, Th1 responses are more effective against intracellular 
pathogens such as influenza virus, while Th2 responses are more effective against extracellular 
bacteria, parasites including helminths and toxins. Influenza virus specific immunity relies on the 
activation of both CD8+ and CD4+ T cells, as CTLs are required to eliminate infected cells and 
B cells stimulated by CD4+ T cells produce anti-influenza virus antibody necessary for the host 
to overcome this infection. 
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 Naïve B cells express MHCII molecule and can present antigen. They are activated by 
helper T cells that respond to the same antigen and induce differentiation into antibody 
producing plasma cells which can produce high levels of antibody. IgA, IgG and IgM are all 
produced during primary infection. IgA and IgM are found predominantly in the infected 
mucosal tissue and IgG is prevelant in the serum. Secondary infection leads to antibody 
production of increased specificity, and all three antibody isotypes can be found in serum. IgM 
and IgG antibodies can be produced by Th cell dependent or independent routes, and are vital to 
the immune response against the influenza virus (128). Antibodies can neutralize viral infectivity 
by interfering with virion binding to receptors, blocking uptake into cells, preventing uncoating 
of the genomes in endosomes, or causing aggregation of virus particles.  
 Another characteristic of the acquired immune system is the formation of ‘memory’ T 
and B cells. When B cells and T cells are activated and undergo clonal expansion, some cells 
become memory cells. Upon interaction with a previously encountered antigen, the appropriate 
memory cells are selected and activated. In this manner, the second and subsequent exposures to 
an antigen produce a more efficient and faster immune response.  
Original Antigenic Sin 
The memory response also leads to a concept called ‘original antigenic sin’ described 
more than 50 years ago (59) that may influence immune response to influenza virus infection in 
young versus older populations. Influenza viruses evolve via antigenic drift, and less frequently 
via antigenic shift. Therefore, during the emergence of a new strain, the new virus may contain 
structural components from viruses that arose many years before in previous pandemics or just 
during the seasonal influenza cycle. For example, the 2009 H1N1 virus emerged and quickly it 
was shown that this new virus shared some homology with past H1N1 viruses (204). It was 
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expected that upon exposure to this variant strain, the immune system responds by activating 
both memory cells that recognize shared epitopes on the virus, and naïve cells that recognize 
novel epitopes. The concept of ‘original antigenic sin’ suggests that regardless of the novel 
epitopes, an individual (usually older individuals who have memory cells specific for the shared 
epitopes) will respond by preferentially activating memory cells. It would usually be the first 
influenza virus strain that they encountered in life to which they developed a dominant anti-
influenza antibody response. However, this suggests that the immunity that is generated might be 
targeted to sub-dominant epitopes, and may ignore the dominant epitopes which would be more 
advantageous for the host to recognize and form immunity against (108). This is the primary 
problem highlighted by the concept of ‘original antigen sin’ in the aged host, and it shows the 
importance of development of vaccination strategies that lead to memory T and B cell responses 
which will target conserved structural components among influenza virus strains (157, 223). 
Balancing protective immunity between T cell memory and sufficient antibody would lead to 
better protection in the aged host as well as the young.  
Lung repair and healing 
Severe influenza infection can cause considerable pathology and injury to the lungs and 
respiratory tract. The lungs undergo a repair and healing process enabled by localized progenitor 
cells as well as newly recruited circulating progenitor cells which proliferate, migrate and 
undergo phenotypic differentiation to reestablish epithelial integrity and function. In the airways, 
non-ciliated epithelial Clara cells are also capable of functioning as facultative progenitor cells 
following injury. At the alveolar level, the ATII cells act as progenitor cell to replenish both AT I 
and AT II cells. Growth factors, cytokines and matrix metalloproteinases (MMPs) are released 
during repair. Growth factors Hepatocyte growth factor (HGF) and keratinocyte growth factor 
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(KGF) stimulate the proliferation and migration of cells in the injured tissue (236). MMPs 
degrade cell-matrix interaction, enabling cell spreading and migration. Cytokines are also 
important in that they stimulate or decrease the migration of immune cells (macrophages, 
neutrophils, etc.) that are involved in the immune response as well as healing response (33). 
Recently, innate lymphoid cells have been implicated in lung repair responses. These cells 
produce Th cell-associated cytokines but do not present T cell receptors or any other cell surface 
markers associated with immune cell lineages. They produce a protein called amphiregulin that 
may contribute to tissue repair after influenza infection (152) 
Immunosenescence 
 The natural aging process causes a gradual decline in immunity, an increase in 
susceptibility to infectious diseases and greater incidence of chronic infections and diseases of 
inflammation in the elderly. This impairment in immunity is known as immunosenescence, and 
affects both the innate and the adaptive immune system. Many factors contribute to this and not 
all of them have been clearly elucidated. Numerous studies have shown immunosenescence in 
healthy aged individuals as well as in individuals in a diseased state. A significant consequence 
of this phenomenon is decreased vaccine efficacy in the elderly population. Thus, it is important 
to study immunosenescence and infections in the elderly. The next few sections will review the 
aging immune system and its effects on the adaptive and innate immunity to pathogenic 
stimulation.  
 Aging is associated with involution of the thymus, which begins during puberty in 
humans. The size of the naïve T cell pool depends on output from the thymus and not cell 
multiplication, so thymic involution reduces its contribution to the naïve T cell pool. The 
activated or memory T cell pool size can be increased through cell multiplication, so thymic 
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involution may not directly affect this. There is no significant decline in the total number of T 
cells in the peripheral T-cell pool, however there are considerable shifts in the ratios of both 
pools of cells, with an increase in the number of activated and memory T cells as well as 
exhausted T cells that are not as efficient in responding to stimuli as T cells from young subjects 
(12). Also intrinsic defects in T cells have been suggested to contribute to skewed immune 
responses in aged subjects, which will be discussed later in this review. Therefore thymic 
involution may be a contributing factor to immunosenescence, but it is not the sole mechanism 
responsible for the impairments.  
Inflammaging  
The normal aging process causes a low grade of chronic systemic inflammation, 
sometimes called “inflammaging”. This was first suggested by Fagiolo et al (50) when they 
reported greater concentrations of inflammatory cytokines from PBMCs of aged people than 
young subjects. This may be caused by exposure to persistent antigens or low level of chronic 
infections. It is not yet clear whether this contributes to increased immunopathology in aged 
hosts upon infection. A production of acute phase proteins such as IL-6, TNFα and CRP in the 
plasma, and pro-inflammatory genes in liver, brain and other organs confirms the occurrence of 
inflammaging prior to infection (11, 82).  The potential role of anti-inflammaging agents to 
promote longevity and healthy aging has also been speculated (58).  Inflammaging in the lungs 
has been reported as well, with regard to T and B cells, T and B signaling molecules, 
macrophages and chemokine receptors. The increase in inflammation may link to changes in T 
cell signaling and/or function, though it has not been clarified yet (125).  
Adaptive immunity and aging 
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Changes in the adaptive immune response with age have been well documented. Studies 
in this field started in the 1980s when a gradual decrease in mitogen-induced proliferative 
responses with increasing age was observed (156).  After the initial observations, many groups 
have reported overall decreases in hematopoietic stem cell (HSC) tissue in the bone marrow of 
aged mice, along with decrease in T and B cell precursors (43). As mentioned above, thymic 
involution reduces the circulating naïve T cell pool. However it has been speculated that the 
repertoire of naïve T cells (and their T cell receptors) are more important in responding to 
infections rather than the number of naïve T cells, knowing that very few naïve T cells (20-200 
antigen-specific T cells) are initially necessary to develop specific immunity to a particular 
pathogen. An age-associated dysfunction in the T cell repertoire has been reported compared to a 
broader repertoire available in a younger host (6, 242). 
 T regulatory cells (Tregs) serve an important regulatory function to the immune system 
upon infection, and are important in maintaining self-tolerance in the absence of infection (149, 
188).  Treg cells may also suppress the immune response to respiratory viral infections (177), 
and have been shown to suppress IFNγ production in Leishmania major infection, contributing to 
a chronic infectious state in elderly individuals infected with this pathogen (120). Studies have 
shown that Treg numbers accumulate in blood of aged human subjects and lymphoid tissue of 
aged mice. Increase in Tregs may contribute to recurrence of chronic infections, for example 
Leishmania major (119), and suppress anti-tumor responses in aged mice. Th17 responses are 
also increased with age, with greater numbers of Th17 cells, and higher amounts of IL17 and IL6 
produced by splenic CD4+ T cells from old mice when stimulated with anti- T cell antigen 
receptor antibodies (95). The presence of more Tregs is thought to utilize the IL2 that would 
otherwise inhibit expression of IL17, and so the increase in Tregs is also though to skew the 
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immune response towards a Th17 type (88, 95). Th17 cells have been implicated in age-
associated autoimmunity (167) and Th17 cells could have a similar role in inducing the low-level 
chronic inflammatory condition associated with inflammaging. 
 A number of studies have elucidated the defects in CD8+T cell population with aging. 
Naturally occurring contraction of the naïve T cell repertoire results in impaired CD8+T cell 
responses to known immunodominant epitopes and decline in heterosubtypic immunity (88, 
242). Impaired cytotoxic killing by CD8+T cells was observed in aged mice in comparison to 
young mice after influenza virus infection. Aging also leads to a loss in CD28, which is the 
receptor for the costimulatory molecules CD80 and CD86 expressed on antigen presenting cells 
(41). The reduction in CD8+ CD28+ T cells in aged hosts suggests that the intrinsic capability of 
these cells to respond to antigenic stimulation is at least partially impaired. T cells with memory 
phenotype (CD45+ RO in mice) are increased and constitute a greater portion of the T cell 
repertoire, leaving fewer naïve T cells to respond to novel pathogens.  
 Age-related defects in CD4+ T cells have also been well studied. As discussed before, 
CD4+ T cells interact with APCs (mostly DCs) presenting antigens bound to MHCII molecules. 
CD4+ T cell impairments with age begin with defects in cytoskeletal reorganization triggered by 
initial contact between TCR and peptide-bearing APC, contributing to defective activation of 
protein kinase-mediated signals in the first few minutes of the activation cascade (66).  This 
defect then contributes to the well-documented reduced proliferation of CD4+ T cells from aged 
mice. Additionally, aged naïve CD4+ T cells have reduced ability to produce significant levels of 
IL-2 upon TCR stimulation, which subsequently leads to the generation of poorly polarized Th 
subsets (87). As a consequence of reduced IL-2 production, CD4+ T cells from old mice may 
have reduced CD40L (CD154) expression, which is required in interactions between B and T 
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cells. This may lead to a poor activation of B cells and an inefficient B cell response. IL-2 is also 
important to induce IFNγ production by CD8+ T cells and a defect in IL2 could potentially affect 
the CD8+ T cell response as well. Naïve CD4+ T cells  
from aged subjects have also been shown to be less sensitive to IL12 and IL4 that may reduce 
Th1 and Th2 or Th9 responses. They still maintain their ability to respond to TGFβ and IL-23 
which would induce the Th17 phenotype. A decrease in cytokine production by Th1 cells, as 
compared to Th2 cells, was noticed with an influenza vaccine challenge (143). Defects in CD4+ 
T cell functions, loss of T cell markers and co-stimulatory molecules CD40L (CD154) and CD28 
in aged mice lead to defects in B cell expansion, differentiation and antibody production, affinity 
maturation and class switching (46, 61-63, 85, 86, 88). Upon transfer of CD4+ T cells from old 
TCR transgenic hosts to young hosts, there was significantly reduced expansion and germinal 
center differentiation of the antigen-specific B cell population after immunization (46).  
Therefore an impaired CD4+ cell population in the aged leads to a defect in the B cell response 
as well. 
 The generation of conventional B cells (or B2-B cells) from bone marrow precursors is 
impaired in old mice, and peripheral B cell percentages and numbers significantly decrease with 
age in humans. Naïve B cell numbers are reduced with age, and information on memory B cell 
numbers and percentages is still uncertain. Increased numbers of B cells with auto-reactive 
specificities and increased amounts of serum auto-antibodies have been reported in old mice. B1-
B cells may either accumulate or expand with age as a result of chronic stimulation by 
environmental antigens (60).  The ability to make an optimal antibody response to exogenous 
antigens and vaccines declines with age in humans and animal models. The changes in the 
humoral immune response with age are both qualitative and quantitative. In particular, a 
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progressive decline in both the number and the size of germinal centers has been reported (46). 
With advancing age, there is a decrease in serum concentrations of antigen-specific antibody, 
antibody specificity, affinity, and class switch recombination (CSR). CSR, the DNA 
recombination process required for the generation of switched antibodies, is initiated by 
activation-induced (cytidine) deaminase (AID).  This enzyme causes deamination of cytidine 
residues in switch (S) regions, thus creating uracils, and the resulting mismatches are recognized 
by specific enzymes and excised, leading to DNA double strand breaks and rejoining at different 
regions of the chromosomes and production of different class of antibody. A decrease in 
expression of transcription factor E47 and AID in B cells also leads to poor class switch 
recombination, as demonstrated by in vitro studies which showed that the splenic B cells from 
old BALB/c mice were deficient in CSR and secondary Ig production (62, 63).  The total number 
of CD19+ B cells, and mature human B cells decrease, whereas the number of late memory and 
exhausted memory B cells increased (61). This results in decreased antibody affinity maturation, 
switched memory B cells and plasmablasts upon immunization in the elderly. There are also 
diminished recirculating antibody-secreting plasma cells in the bone marrow (60).  
Vaccinations in the elderly population 
The impairment of the adaptive response results in a major problem, which is the 
impaired response to vaccinations in the elderly population. There are currently two types of 
vaccines, an injectable flu shot and a nasal spray. The flu shot consists of inactivated (killed) 
influenza virus, given intramuscularly and approved for use in higher doses for people 65 and 
older. The high dose vaccine contains 4 times the amount of antigen contained in regular flu 
shots (24). Current regular influenza vaccines contain 15 µg of the hemagglutinin of A/H1N1, 
A/H3N2, and B strains, respectively, and are administered to induce serum anti-hemagglutinin 
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antibody for prevention of subsequent infection and illness from natural influenza. The high dose 
vaccines were developed to meet the need for a higher efficiency vaccine for the elderly 
populations. The efficiency of the regular trivalent inactivated influenza vaccine responses in 
individuals above 65 years of age were reduced compared to young individuals (123). A large 
study performed in the Netherlands during the 1991-1992 influenza season reported that the 
effectiveness of the influenza vaccine decreased with increasing age groups (57% in people aged 
60–69 years and 23% in volunteers aged ≥70 years) (74). New strategies to improve the response 
to vaccinations in the elderly are still being developed at present. A few recent studies used a 
platform that links viral epitopes to flagellin, a TLR 5 activator and this induced anti-influenza 
immunity in aged mice as well as aged people (130, 218). This makes it imperative to uncover 
the underlying mechanisms of the aging response to infections and vaccinations. 
The live attenuated vaccine consists of the same three strains of live, attenuated virus and 
is given by an intranasal dose to people between the ages of 2 to 49 years of age (25). 
Alterations in cells of the immune system. 
Dendritic Cells 
DCs are potent antigen-presenting cells that have the capacity to stimulate naïve T cells, 
and are thus called the link between adaptive and innate immunity. These cells are also affected 
by the aging process. DCs become more sensitive to self-antigens (e.g., human DNA) and 
increase activation markers (CD80 and CD86) enabling enhanced T cell activation against these 
self-antigens (5).  An increase in basal levels of inflammatory factors like NFκB and cytokines 
without stimulation (thus contributing to inflammaging) and a decreased response of 
inflammatory cytokines such as TNF-α and IL6 to TLR stimulus demonstrates the impairment of 
the DC response with aging (169, 238).  However there is still conflicting data on this topic and 
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reports on changes in DC numbers with age are also variable. The number of myeloid DCs 
(mDCs), but not pDCs in human peripheral blood Dendritic Cells (PBDCs) declined with age in 
one study (37) whereas other groups noted a decline in pDCs, but not mDCs (3, 102, 197). In 
addition, a decrease in human Langerhans cell (LC) densities has been observed in the epidermis 
of the skin of aged subjects (76) and in aged mouse studies. Reduced expression of TLRs has 
also been suggested as a consequence of aging, demonstrated by reduced TLRs 1, 3 and 8 in 
cDCs and TLRs 7 and 9 in pDCs from aged individuals (102, 169). Also, defects in antigen 
capture by DCs, phagocytosis and pinocytosis have been suggested though this is still being 
investigated (2). Reduced migration of DCs to the lymph nodes and/or to the infected tissues 
may also contribute to age-associated immune dysfunction (4, 222). Defects in DCs can 
influence the adaptive immunity, especially T cell response to infections, as they are 
instrumental in activating these cells. This was suggested in a report where adoptive transfer of 
young DCs to old mice augmented the CD8+ T cell response (101). 
Neutrophils and Macrophages 
Neutrophils and macrophages are key components of the inflammatory response that 
shape immune responses and participate in the breakdown and repair of tissue. During influenza 
infection, they are the initial responders to be recruited to the lungs. The changes in neutrophils 
with age have not been completely clear so far. Neutrophils have been implicated in the 
pathogenesis of atherosclerosis, Alzheimer’s disease and cancer. Data on changes in number of 
circulating neutrophils have been inconsistent , though some data suggest an impairment in 
chemotaxis of human neutrophils and defects in the respiratory burst (39). 
 After leaving the BM and entering the blood, monocytes differentiate continuously into 
macrophages en route to peripheral tissues. Given the plasticity of macrophages in specific 
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tissues, it is not very surprising that age-dependent changes in macrophage function may occur in 
a tissue-specific manner (115). The number of macrophages in the elderly and young appears to 
be similar, but macrophages from aged populations have less MHC II gene expression.  
Macrophages have been shown to have reduced phagocytic capability, delayed migration, 
impaired formation of reactive oxygen species, and formation of nitrogen intermediates 
important for antimicrobial activity (176). Chemokine/cytokine production and TLR expression 
on macrophages is also reduced with age. Some of these changes will be discussed later in this 
review.  
NK cells 
NK cells are defined by their ability to kill cancer cells and virally infected cells without 
prior sensitization. Two distinct populations of human NK cells can be identified based on the 
cell surface density of CD56. CD56bright NK cells are the primary source of NK cell-derived 
immune-regulatory cytokines such as IFNγ, TNF-β, granulocyte macrophage-colony-stimulating 
factor (GMCSF), IL10 and IL13. This subtype is rare in peripheral blood (∼5%) and more 
frequent in lymph nodes (∼95%). The majority of peripheral blood NK cells (∼95%) belong to 
the CD56dim NK subset, which produces low levels of NK-derived cytokines and potently 
mediates natural cytotoxicity. Changes in NK cell numbers are dependent on the NK subsets. 
CD56bright (cytokine producing) NK cell subset is reduced (30), whereas CD56dim (cytotoxic) NK 
cells are increased with age (7, 18, 68). Increases in the expression of NK-related receptors, such 
as CD16, CD56, CD57, and CD94, on the T cells of elderly persons have been reported, coupled 
with a down-regulation of the inhibitory receptor KLRG1. This may be a compensatory 
adaptation, given that the overall T cell receptor diversity is decreased during aging. Changes in 
NK cell cytotoxicity are still controversial. While some studies suggest a decrease, others studies 
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report no change in cytotoxicity (7, 78). In a study using ectromelia virus (murine equivalent of 
smallpox virus) infection in aged mice, defects in NK cell numbers and trafficking led to 
increased lethality and defective viral clearance. This defective migration was associated with 
reduced up-regulation of CD62L (also known as L-selectin), which is an adhesion molecule that 
allows attachment of cells to high endothelial venules. The defects in NK cells may have led to 
impaired CD8 T cell responses in the infected mice (51).   
In summary, defects in innate cells such as DCs or NK cells of aged individuals have the 
potential to influence adaptive and memory responses to virus challenge and consequently 
effectiveness of vaccinations in the elderly.   
Aging and the innate immune system 
The innate system has three broad groups of receptors that alert the body to the presence 
of viral infections –  Toll Like receptors (TLRs), RIG Like receptors (RLRs), and NOD Like 
receptors (NLRs). However, activation of these pathways by a specific virus may not be 
mutually exclusive as exemplified by influenza viral lung infection. The influenza viral infection 
activates TLR7 within pDCs and activates RLRs within alveolar macrophages to induce type I 
IFN responses. TLR 3 and TLR 9 on myeloid and pDCs also respond to influenza viral antigens 
to activate type I IFN and inflammatory cytokines. The number of circulating pDCs and type I 
IFN response may be reduced in healthy aged individuals (22, 102, 169, 197). Age impairs the 
type I IFN response to viral infections including influenza, HSV-2 or West Nile virus in human 
and mouse models (22, 180, 212). Aging impaired the up-regulation of IRF7, a critical 
transcription factor in the type I IFN signaling pathway in two studies using HSV-2 infection in 
murine pDCs and influenza infection in human pDCs (169, 212). Aging also compromises the 
TLR responses in studies using either human PBMCs or mouse models (117, 169, 182, 228). 
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Reduced baseline TLR1 surface expression, along with a decline in TLR1/2 induced TNFα and 
IL6 was observed in human PBMCs (228) while the same cytokines were decreased in mouse 
macrophage cultures in response to various TLR stimuli (182). The latter group also reported a 
decline in all TLR expression on splenic and activated macrophages. Similar data were seen in 
primary human DCs, with lowered levels of TLRs 1, 2 and 8 and production of TNFα, IL6 and 
IL12p40in mDCs along with decreased levels of TLR7, TNFα and IFNα in pDCs, in response to 
TLR stimuli (169). 
 However, suppression of TLRs and cytokine response is not the only means by which the 
immune response to viruses is impaired with age. Elevated IL-6 responses to TLR activation 
have also been recently documented in aging baboons (144).  HSV-2 infection led to higher 
mortality in aged mice due to overproduction of pro-inflammatory cytokines. Also, higher levels 
of IL17a were produced by liver NKT cells along with more MCP-1 and neutrophil infiltration 
(211). West Nile virus infection in macrophages from old subjects impaired the TLR3 response 
with age such that higher expression of TLR3 resulted in more cytokine response and higher 
mortality, as compared to young subjects in which lack of or suppression of TLR3 led to 
resistance to the neurological complications of this infection (117). Studies comparing influenza 
infection in young/adult and aged mice noted an increase in morbidity in aged mice (222), with a 
delay in viral clearance (16, 222), total cell infiltration and APC activation in the lungs (222). 
The same study found a corresponding delay in production of neutralizing antibody, and 
chemokines KC, MCP1and MIP1β. Correlating with the delay in viral load, there was a delay in 
adaptive responses as well, with delayed infiltration of CD8+ and CD4+ T cells into lungs of 
infected mice (222), impaired cytotoxic T lymphocyte (CTL) activity and a delay in epithelial 
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necrosis in the lung (16). To our knowledge, no studies have been reported on the changes in 
innate immune proteins such as pentraxins, MDA-5, RIG-I or α/β defensins. 
 Autophagy is another cellular pathway affected by age. This pathway was impaired in 
aged rat and mouse models (34, 42, 219) and restoration of autophagy machinery restored some 
of the longevity of the model organisms (186). This pathway has been implicated in pathogenesis 
of age-associated neurodegenerative diseases (e.g., Parkinson’s disease) and cancer, and also 
other liver, muscle and cardiac diseases. The contributions of autophagy to immunity have been 
discussed earlier, although the effect of autophagy impairment in infectious disease in the elderly 
has not been elucidated.  
Exercise and the immune system 
 A growing body of research evidence supports the belief that exercise “enhances” the 
immune response. Physical exercise is associated with increased longevity and a lower risk of 
developing cardiovascular disease (CVD), diabetes, hypertension, infectious illnesses and 
cancer. Other physical and mental interventions such as yoga and meditation have also been 
explored and may improve physical and mental health (14, 184). The effect of exercise on the 
immune response depends on the duration and intensity of the exercise itself. In the early 1990s, 
Neiman proposed the “J” curve relationship between exercise intensity and risk of upper 
respiratory tract infections (URTI) (160).  This model suggests that none or very low intensity 
exercise and high intensity exercise increase the risk of URTI, while moderate intensity exercise 
minimizes the risk of infection. Neiman’s work showed that moderate intensity of regular 
exercise led to fewer reported symptoms associated with URTIs. Also ongoing research shows 
that acute sessions of exercise have different (possibly short term) effects on immunity as 
compared to chronic exercise training.  
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Acute Effects of exercise on immunity 
A few studies have reported increased risk and incidences of URTIs in runners within a 
few weeks after a marathon race or similar endurance exercise event (162, 172), although other 
results have challenged this finding (49). The circulating numbers and functional capacities of 
leukocytes may be decreased by repeated bouts of intense exercise. A single, acute bout of 
increases the number of circulating memory T (CD45RO+), naïve T (CD45RA+) cells and 
neutrophils, pro-inflammatory cytokines such as TNFα, MIP-1 and IL1β, anti-inflammatory 
cytokines like IL6, IL10, IL1ra (IL 1 receptor antagonist), and acute phase protein C reactive 
protein (CRP) (166). The increase in plasma IL6 can be accounted for by release from 
contracting muscle (210).   Also, IL6 production by monocytes and IL2 or IFNγ production by T 
cells are inhibited after prolonged exercise, and so these are not the cause for the increase in 
plasma concentrations of these cytokines (71). Acute exercise temporarily increases the number 
of circulating NK cells, but this along with cytolytic activity (per cell) decreases after exercise. 
Acute exercise also diminished the proliferative capacity and activation markers of lymphocytes 
and MHC II expression and antigen presenting capacity of macrophages. It has been 
hypothesized that lymphocytes are recruited to circulation from tissue pools such as the spleen, 
lymph nodes and the gastrointestinal tract during exercise (but not the lung) and are redistributed 
back into tissues after exercise or during prolonged and/or high intensity exercise. However, the 
organs or tissues that these cells are redistributed to are still not clear (170). Lymphocyte 
proliferation in response to T cell mitogens phytohemagglutinin and concanavalin A decreases 
during and immediately after exercise (159), although this may reflect the decrease in percentage 
or proportion of lymphocytes in tissue after recruitment to the blood.  
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 Exercise activates the hypothalamic-pituitary-adrenal axis and hormonal changes occur in 
response to exercise. This includes increases in the plasma concentration of several hormones 
such as the catecholamines epinephrine (adrenaline) and norepinephrine, growth hormone, β-
endorphins, testosterone, estrogen, cortisol, and prolactin, which are known to have immune-
modulatory effects (118, 170). Muscle-derived IL6 appears to be at least partly responsible for 
the elevated secretion of cortisol during prolonged exercise, via stimulating ACTH from the 
anterior pituitary gland or by stimulating release of cortisol from the adrenal glands (71). T, B, 
NK cells, neutrophils and macrophages express β-adrenergic receptors that are targets of 
catecholamines. Both cortisol and epinephrine suppress the Th1 cytokine production, whereas 
IL6 directly stimulates Th2 cytokine production. So exercise also disturbs the Th1/Th2 cytokine 
balance, decreasing the percentage of IFNγ+ Th1 cells in circulation (122).While the decrease in 
Th1 response might be harmful in case of viral URTI infections in athletes, a shift towards Th2 
response might be beneficial by reducing the cellular damage and inflammation.  
Chronic effects of exercise training on immunity 
Studies involving long term exercise training tend to range from 8 week to 12 month 
exercise training interventions. Thus the outcomes are variable and dependent on the type, 
duration and intensity of exercise. However, some differences between trained and untrained 
individuals or have been consistently reported, which will be discussed in this section. As 
discussed before, many age-related diseases are attributed to a dysfunctional immune system. 
The impact of exercise on aging immunity could serve as a simplistic, inexpensive and feasible 
method for designing lifestyle changes to combat immunosenescence. In this context, the effect 
of training on aged subjects (human or animal) is provided in this review.  
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 Chronic voluntary exercise changes the age-related gene expression in the heart tissue of 
mice. The changes due to age in these mice were either abrogated or reduced in fold change due 
to exercise (20). Exercise also reversed the decline in neurogenesis and improved learning and 
retention in mice (229).  The findings from these and other studies suggest that it is possible for 
exercise to alter gene expression and/or physiological function in multiple tissues. Some of the 
more specific effects of exercise on the innate and the adaptive immune system will be discussed 
in the following sections. 
Effects of exercise on the innate immune system 
 The effects of exercise on individual cell populations are difficult to detect, and most data 
are obtained from in-vitro or ex-vivo studies using exercise trained subjects. This may be the 
cause of many discrepancies between different studies. Thus far, the research regarding changes 
in cell populations with exercise and aging hasmnb focused on NK cells, neutrophils and 
macrophages, and the TLR response has been the most well-studied innate pathway studied with 
exercise. 
 NK cell cytotoxicity, which may decrease with age, was either increased or unchanged 
with exercise in older individuals, and a clear consensus has not been reached (148, 161, 195, 
243). Age decreases the ratio of CD56 bright: CD56dim (low cytotoxic: high cytotoxic) NK 
cells. The composition of NK cell subsets with exercise have not been studied extensively, 
although one study reported increased proportions of CD56bright NK cells in young subjects 
(214). It has been suggested that the increased ratio of CD56 bright: CD56dim (low cytotoxic: 
high cytotoxic) NK cells may be responsible for the observed reduction in total NK cell 
cytotoxicity due to exercise training. 
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 Fewer studies have examined how neutrophils or monocytes respond to exercise training. 
Training may reduce the number of neutrophils in circulation in obese (young) women (150).  
Increased phagocytosis as was observed in one study with exercise in the elderly group (243).  
Since the effects of age on phagocytic properties of neutrophils are unclear, it is difficult to draw 
conclusions as to whether exercise “rescues” the age-associated impairments with neutrophils. 
A 12 week exercise training intervention resulted in a decreased proportion of 
CD14+/CD16+ monocytes in blood, although monocyte TLR4 expression was unaltered (221). 
Alternatively, older women who exercised moderately had lower TLR4 expression but no 
change in LPS stimulated cytokine production (54, 145).  A recent study found no changes in 
monocyte phagocytic activity in middle-aged men (191). 
 So far no studies involving the effects of exercise on DC activity or TLR expression have 
been conducted.  However, exercise may shift DCs toward a more mature state, because of 
increases in MHCII in bone-marrow derived DCs and DC-induced leukocyte activation and IL12 
production in young rats (29). A recent study involving marathon runners observed a decrease in 
pDCs and TLR7, and an increase in mDCs, and an increase in both pro- and anti-inflammatory 
cytokines immediately after the marathon (these were the acute effects of the marathon). 
However, they concluded that the training level of subjects (therefore, chronic exercisers vs. non-
athletes) did not affect the changes that were seen after the marathon (158). 
 Few groups have studied non-specific antibody levels in trained individuals. Although it 
was suggested that levels of secretory immunoglobulin salivary IgA (s-IgA) may be lower in 
athletes compared to sedentary individuals, recent studies have shown similar s-IgA levels 
except after periods of heavy training. There is a lack of evidence to support any increase in 
specific antibody response to vaccination or delayed-type hypersensitivity responses with long 
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duration training. More research is required to reveal the changes in innate immunity with 
exercise and how it relates to immune response during infectious diseases.   
Effects of exercise on the adaptive immune system 
Exercise training has been seen to affect T cells and vaccine responses in the elderly. 
Although lymphocyte counts remain the same, T cell proliferation, which tends to reduce with 
age, increased with exercise along with naïve CD8+ T cell proportions and a reduction in 
exhausted T cell proportions (161, 195, 207, 243). Exercise was also able to reverse the age 
associated increase in memory: naïve T cell ratio in mice (239) and increase the number and 
percentage of T cells expressing CD28 in older subjects (194). However, exercise did not alter 
the T cell proliferative responses in aged individuals or change CD28 expression (21, 104).  
Some studies have reported increases in IL2 and IL2 producing CD8+ T cells (17, 195). 
This may explain the increase in T cell proliferation observed in some studies. Exercise may also 
cause a reversal of the Th2 type dominance seen in aged subjects, by enhancing type 1 cytokines 
in response to viral infection (112). 
 Exercise may reduce the age associated inflammation, and one possible mechanism that 
has been studied is an increase in FoxP3+ Treg cells. Although not yet studied in aged models, 
these cells were found to be increased with exercise in subjects with type 2 diabetes and in 
number and suppressive function in the mouse model of asthma (136, 244).  
 Moderate exercise decreases mortality in influenza infections in mice (138) and improves 
antibody response to HSV-1 infections in mice (116) and responses to influenza vaccine in 
elderly human subjects (111, 240). Human subjects who exercised at a low to moderate intensity 
had less mortality due to influenza or influenza associated infection, as compared to those who 
did not exercise (237). Mice that performed chronic moderate exercise on a treadmill have 
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reduced illness severity and less virus load in the lungs than mice that did not exercise or mice 
that underwent one session of acute exercise (200). Therefore exercise has the potential to 
ameliorate disease outcomes in several models, and further study has the capability to contribute 
to a healthier lifestyle for the elderly.  
Exercise and response to vaccinations 
 Data from an increasing number of studies suggest that an exercise intervention can 
improve the response to influenza vaccinations in aged (111) as well as young (47, 48) human 
subjects. In the study conducted on aged subjects, a long term intervention with regular exercise 
increased antibody titers to strains used in the influenza vaccine. Studies on young adults (18 – 
25 years of age) determined that a single session of exercise or mental stress could improve 
antibody titers in the female subjects, and the IFNγ response in the male subjects. However, a 
recent study suggested that moderate amount of exercise (a 45 minute brisk walk) was not 
capable of increasing antibody titers to vaccination in both young and old subjects, and a more 
robust bout of exercise is required to improve vaccine responses (135). Further studies 
concerning exercise and efficacy of vaccinations need to be conducted and it remains to be seen 
whether exercise can be suggested as an adjuvant for vaccines.  
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Abstract  
 Multiple age-related defects in T-cell or B-cell response to influenza infection have been 
well documented, but the impact of age on innate host defense to influenza is not well-
characterized. Antiviral innate host defense mechanisms directed against influenza include the 
production of Type I interferon (IFN) and  IFN-inducible gene expression, viral recognition 
involving TLR or RLR signaling cascades, expression of host defense proteins in the respiratory 
tract, and a recently recognized role for autophagy.  Defects of the early innate host antiviral 
pathways could impact early host defense as well as appropriate activation of adaptive immunity.  
Therefore, the aim of this study was to identify age-associated alterations of innate 
recognition/response to influenza virus.   Aged BALB/c mice (17 months of age) and young 
BALB/c mice (2 months of age) were either infected with influenza virus or remained as 
uninfected controls. Lungs and bronchoalveolar lavage fluid (BALF) were collected 6 hours, 12 
hours and 24 hours post infection (PI), and at day 3 and day 8 PI. Uninfected aged mice 
exhibited increased cytokines and chemokines gene expression, illustrating the chronic 
inflammation associated with aging. Aging was associated with decreased PTX3, PKR, β2-
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microglobulin, ADAR1 and few TLR signaling adaptors and constitutive monocytes in the lungs. 
After infection with influenza, aged mice had lower viral load at day 1 but increased viral titer at 
day 3 and day 8. Subsequently, innate activation of genes such as TLR 7 and TLR 9 were 
decreased and activation of ISGs was delayed along with a decrease in cell infiltration of pDCs, 
neutrophils and inflammatory monocytes in the lungs. Our study confirmed inflammaging in 
aged mice, along with a depression of ISGs and possibly TLR signaling with age. Infection with 
influenza virus led to lower viral titer in the initial stages of infection, and lower immune 
activation and cell infiltration in the lungs which could lead to decreased clearance of virus.  
Introduction 
 The elderly population, i.e. individuals above 60 years of age, constitutes approximately 
18.5% of the population in the United States. This represents a 24.6% increase in this population 
in the last decade (Administration on Aging). The elderly are at a higher risk of infectious 
disease, and have higher hospitalization rates due to influenza and related respiratory diseases as 
compared to younger adults (220). In addition to an increased risk of infection, the response to 
vaccinations is also dampened in the elderly (13, 73). This decreased response to vaccination is 
often ascribed to the phenomenon of immunosenescence, a dysregulation of the immune 
response due to age. Extensive research has been conducted in an effort to uncover the causal 
mechanisms and the effects of aging on the immune system.  Multiple changes in the adaptive 
immune response with advancing age have been well documented.  These age related changes 
include an overall decrease in hematopoietic stem cell (HSC) tissue in the bone marrow of aged 
mice, as well as a decline in T and B cell precursors (43), naïve CD8+  cells, and CD4+ T cells 
(61, 222).  Decreased T cell proliferation and defects in function (61, 88) may contribute to age-
associated defects in B cell expansion, differentiation and antibody production, affinity 
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maturation and class switching (46, 61-63, 85, 86, 88).  An accumulation of late memory and 
exhausted memory B cells (43, 61-63), as well as regulatory T cell numbers may contribute to 
recurrence of chronic infections in the elderly (119). 
 However, the impact of age on innate immunity is less clear.  Several studies have 
evaluated innate immune cell numbers and their function, but results have been variable.  A 
decrease in Toll-like receptor (TLR) expression and cytokine production in response to TLRs has 
been observed with age (117, 169, 182, 228). To our knowledge, there are no reports on the 
effects of age on other Pathogen Recognitions Receptors (PRRs) such as Melanoma 
Differentiation-Associated protein 5 (MDA-5), retinoic acid-inducible gene 1 (RIG-I) and 
pentraxin PTX3. These receptors have important roles in detection of influenza virus and 
induction of inflammatory response (105, 126, 181).  Other proteins called antimicrobial 
peptides (AMP) present in the lung environment may act as initial defense in influenza infection. 
These include mouse CRAMP, cathelicidin Related AMP (cathelicidin LL-37 in humans) and 
mouse Ears, eosinophil-associated ribonucleases (eosinophil-derived neurotoxin EDN/RNase 2 
and eosinophil cationic protein ECP/RNase 3 in primates) (154, 226).  An age-related defect in 
any of these host defense pathways could result in increased viral replication and/or impair the 
activation of appropriate dendritic cell priming of T or B cell responses. 
 Autophagy is a highly conserved cellular pathway that has multiple functions in cell 
homeostasis, and was recently recognized as playing an important role in the recognition and 
response to virus infection, although exact mechanisms remain to be clearly identified (129, 
250). Autophagy may contribute to a reduction in inflammation by decreasing necrosis and 
apoptosis, and may inhibit pro-inflammatory signaling via RIG-I like receptors and induction of 
inflammasomes (133, 186, 241). This pathway may influence adaptive immunity by increasing 
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the cross presentation of antigens to dendritic cells (DC) (97). Autophagy is also thought to be 
impaired with age, contributing to immunosenescence and possibly a dysfunctional immune 
response to infections (34, 42, 219).  The process of autophagy was found to be impaired in aged 
rat and mouse models and restoration of autophagy machinery restored some of the longevity of 
the model organisms (186). 
 Aged mice infected with influenza show higher morbidity (222) and a delay in viral 
clearance (16, 222) with a corresponding delay in immune activation, including total cell 
infiltration, antibody and chemokine production, and epithelial necrosis in the lung (16). These 
findings may be suggestive of a decreased activation of innate immunity (and subsequently 
activation of adaptive immunity and CTLs) that could result in a more severe infection with 
influenza. However, one group reported higher inflammation during sub-lethal influenza 
infection and greater mortality during lethal infection than in young mice.  
 Studies of the innate response with age in humans have been limited to in vitro and ex 
vivo studies on human peripheral blood mononuclear cells (PBMCs) from geriatric populations 
(22, 37, 102). Although defects of T and B cell function have been reported, particularly in 
response to influenza vaccination, very little has been published regarding the impact of age on 
innate host defense against influenza virus in humans.  Based on findings from only two studies, 
a decrease in frequency of type I IFN producing plasmacytoid dendritic cells (pDC) and cytokine 
production of IFNα, IL6 and TNFα was noted in PBMCs from aged individuals in response to 
stimulation by influenza virus (22, 102). Such systems have the disadvantage of being isolated 
cell systems and may not fully represent the effects of aging on the tissue response to infection.  
Therefore, the purpose of this study was to determine whether age impairs different aspects of 
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the innate host defense against influenza, and whether influenza infection leads to a different 
outcome in aged mice than young mice.  
Materials and Methods 
Animals, virus and infection 
 Aged BALB/c mice (male, 17 months of age, n= 6 to 10) and young BALB/c mice (male, 
2 months of age, n= 6 to 10) were obtained from Charles River NIA aged mouse colony. Mice 
were anesthetized using aerosolized isoflurane and infected via an intranasal route with influenza 
virus strain A/PR/8/34 (H1N1) at doses of 163.84 HA units, 0.041 HA units and 0.02 HA units 
per mouse (stock virus – HAU= 1024/0.05mL or 10^9.5/mLEID50 diluted 1:6.25, 1:25,000 and 
1:50,000 in sterile saline). 
 An experiment was conducted to ascertain the viral load post infection with influenza 
virus dose adjusted to lung weight and volume (which varied between young and old mice). 
Therefore, old and young mice were infected with H1N1 A/PR/8/34, adjusting the viral dose to 
the average lung tissue weight of each group. Lung tissue weight and volume of old mice was 
found to be about twice that of young mice, therefore viral doses were calculated accordingly. 
This was done to ensure that all mice were infected with the same amount of virus per mg tissue. 
A group of old mice (Group 1 OLD, n= 8) and a group of young mice (Group 1 YOUNG, n= 8) 
were infected with 1:25000 dilution of influenza virus (labeled dose 1). Another group of young 
mice (Group 2 YOUNG, n=8) was infected with a 1:50000 dilution of influenza virus (labeled 
dose 2). Viral load was then measured using qRT-PCR in lungs and broncho-alveolar lavage 
fluid (BALF) collected at day 3 and day 8. 
 Non-infected controls for each group were housed separately from the infected mice. 
Following infection with PR8 virus, mice were weighed every 24 hours until necropsy. All 
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animal procedures were approved by the Institutional Animal Care and Use Committee 
(IACUC). 
Tissue collection  
 Mice were euthanized by cervical dislocation at 6 hours post infection (PI), 12 hours PI, 
or 24 hours PI.  In some experiments mice were euthanized at either 3 or 8 days PI.  Lung lobes 
were collected and used to determine viral titers. Remaining lung tissue was collected for RNA 
isolation and flow cytometry. RNA was isolated using TRIzol Reagent (Invitrogen, Carlsbad, 
California).  Lung RNA was further purified using the RNeasy Micro Kit (QIAGEN, Valencia, 
California) then frozen at -80°C until further testing was carried out by PCR. Lungs were 
homogenized in collagenase containing media and single-cell suspensions of lungs were 
obtained using a 40µm cell strainer and used for flow cytometry.  Broncho-alveolar lavage fluid 
(BALF) was collected by inserting a catheter attached to a syringe through an incision in the 
trachea, and airways were flushed three times with 1 mL of PBS. The BALF was centrifuged, 
cells were collected for analysis by flow cytometry, and the supernatant was stored at -80°C until 
subsequent analysis.  
qPCR and PCR Microarray 
 1000 ng of purified lung mRNA was analyzed for gene expression using the 96-well 
Mouse Toll Like Receptor Pathway RT² Profiler™ PCR Array and Autophagy Pathway RT² 
Profiler™ PCR Array (SABiosciences, Frederick, Maryland) and the protocol provided with the 
array. Samples were analyzed using a BioRad iCycler and corresponding MyIQ Optical System 
Software Version 1.0. Customized primers were designed for IFNα/β subunits and Interferon 
stimulated genes (ISGs) using Primer Express software and obtained from Applied Biosystems. 
GAPDH, beta actin and beta galacturonidase were used as the reference genes/housekeepers. 
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Identification of Lung Cell Populations by Flow Cytometry 
 Cell populations were determined in lungs and BALF from uninfected old and young 
mice, and from infected mice that were euthanized on day 1 PI. Live cells were gated by 
comparing forward scatter with side scatter and deselecting the cells with low forward and side 
scatter. Alveolar macrophages (Highly autofluorescent, CD11c high, CD11b low, Gr1 negative), 
constitutive monocytes (CD11b positive, Gr1 negative), pDCs (CD11b low, CD11c intermediate, 
mPDCA positive, low autofluorescence), neutrophils (CD11c negative, CD11b positive, Gr1 
high, high side scatter) and inflammatory monocytes (CD11b positive, Gr1 high, CD11c 
negative, low side scatter) were identified in cells obtained from whole lung homogenate and 
BALF. Flow cytometry was performed using a FACSCanto flow cytometer. FlowJo 7.6 software 
was used for gating and analysis. 
Determination of viral titer 
 Mice were euthanized at multiple time points post-infection and viral load was assessed 
in the lungs. Virus titers were measured by a quantitative fluorogenic reverse transcription-
polymerase chain reaction (real-time RT-PCR) using TaqMan® chemistry.  Using sequences 
deposited in GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html) and Influenza 
Sequence Database (http://www.flu.lanl.gov), virus-specific oligonucleotide primers and a 
fluorescent probe were engineered to target a highly-conserved region of SIV NP gene.  The 
forward primer (SIVRTF:  5’- CGGACGAAAAGGCAACGA-3’) and reverse primer (SIVRTR: 
5’- CTGCATTGTCTCCGAAGAAATAAG-3’) were synthesized by a commercial vendor 
(Integrated DNA Technologies, Coralville, IA, USA).  A TaqMan® MGB probe with a 5’ 
reporter 6-carboxyfluorescein (FAM) and a 3’ non-fluorescent quencher (SIVRTP: 5’-6FAM- 
CCGATCGTGCCYTC) was synthesized by Applied Biosystems (Foster City, CA, USA).  To 
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conduct the assay, viral RNA was first extracted from 50 µl of lung sample, positive control 
(H1N1 and H3N2 swine influenza viruses) and negative control (elution buffer) using the 
Ambion® MagMAX™ Viral RNA Isolation Kit (Applied Biosystems) and KingFisher® 96 
magnetic particle processor (Thermo Scientific, Waltham, MA, USA).  Real-time RT-PCR was 
then carried out with the QuantiTect® Probe RT-PCR Kit (Qiagen, Valencia, CA, USA) in a 20 
µl reaction volume using 4 µl of extracted template.  Primers were added at a final concentration 
of 0.4 µM each and the probe was at a final concentration of 0.2 µM.  The PCR amplification 
was performed on the ABI 7900HT Sequence Detection System (Applied Biosystems, Foster 
City, CA, USA) with the 384-well format.  Cycling conditions were as follows:  a) reverse 
transcription for 30 min at 50° C; b) a 15 min activation step at 95° C, and c) 40 cycles of 15 sec 
at 94° C and 60 sec at 60° C.  A set of influenza preparations, each with a known virus titer 
(EID50/ml), were used to generate a standard curve.  Samples with threshold cycles (Ct) ≤35 
were considered positive.  The amount of influenza in each sample was calculated by converting 
the Ct value to a virus titer using the standard curve. 
Statistical Analysis 
 Statistical analysis for lung and BAL cell populations was performed using SPSS 
Statistics 17.0. A one-way ANOVA was used to compare difference between young and old 
mice.  Viral titer data was log transformed and a one-way ANOVA again was used to compare 
difference between young and old mice.  In order to compare body weight post-infection, a 
repeated measures ANOVA was used. Statistical trends were denoted by p<0.1 and significance 
levels for all tests were set at p<0.05. The false discovery rate was calculated as the q value for 
PCR results. Statistical trends were denoted by q <0.1 and significance levels were set at q<0.05. 
Results 
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Differences in viral titer in young and old mice 
 Old and young mice were infected with Influenza A/PR/8/34, and body weights and food 
intake were measured every 24 hours post infection to assess symptoms and evaluate illness 
severity (Figure 1). All mice infected with influenza lost weight during the course of the 
infection. Weight loss in old mice began at day 2 PI, whereas weight loss in young mice did not 
occur until day 5 PI. Overall, old mice lost more weight than young mice over 8 days of 
influenza infection (compare groups ‘young dose 1’ to ‘old dose 1’ in figure 1). Viral load was 
measured by qRT-PCR in lungs collected from mice at day 3 and day 8 after they were infected 
with influenza virus. The log of viral load was compared between groups (Figure 2B). Old mice 
had higher viral burden in lungs at both day 3 and day 8 after infection (p<0.05).  To assess the 
effect of age on viral load early in the course of infection, mice were euthanized day 1 post 
influenza infection and viral load was measured. Old mice had lower viral load in BALF and 
lungs as compared to young mice (Figure 2A).   
Body weights and viral load were measured in Group 1 OLD and Group 1 YOUNG that 
were infected with 1:25000 dilution of influenza virus (labeled dose 1) and Group 2 YOUNG 
that was infected with a 1:50000 dilution of influenza virus (labeled dose 2). Group 1 YOUNG 
and Group 2 YOUNG mice had similar weight loss (Figure 1B) and viral titers (Figure 3A), even 
though they received different virus doses. Both groups of young mice had less viral load in the 
lungs than old mice at both day 3 and day 8 (Viral load was then measured using qRT-PCR in 
lungs collected at day 3 and day 8 (Figures 3A and 3B).  
Age increases expression of cytokines and chemokines associated with inflammation prior to 
infection, but decreases inflammatory and activation markers day 1 after infection. 
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 Healthy (uninfected) aged mice showed higher expression of chemokines CCL2 (MCP-
1), CXCL10 (IP-10), cytokines IL10, IL1β, IL6, IFNγ, CSF2 (GM-CSF) and TNF when 
compared with young mice (Figure 4A). This suggests that an increase in basal levels of these 
cytokines and chemokines may contribute to the “inflammaging” phenomenon that has been 
reported in aged animals. Mucin encoding gene MUC13, and Ly86 were also increased prior to 
infection.  
 A panel of activation and inflammatory markers were detected at day 1 post influenza 
infection. The fold change in old mice after infection was less than the fold change in young 
mice for many of the genes detected, such as CD80, CD86, CLEC4e, IFNγ, IL1b, MUC13, 
Ly86, TNF, CCL2, IL6 and CSF3 (Figure 4B).    
Influenza infection induces the expression of PRRs in young and old mice 
 Data in Tables 1A and 1B illustrate the impact of influenza infection on gene expression 
related to pattern recognition receptors (PRR’s) (Table 1A, 1B). Influenza infection in young 
mice induces the expression of TLRs 1-9 and associated gene MyD88. TLR3, TLR7 and TLR9 
were strongly induced as early as 12 to 24 hours after infection, along with PDCD-1, MDA-5, 
mEAR1 and PTX3 day 1 PI. Clec4e, a recognition protein associated with bacterial infection was 
also increased upon infection (Table 1A).  
 Infection with A/PR/8/34 in old mice induced PRRs such as TLRs 1, 2, 3 and 9, MDA-5, 
mEAR1 and PTX3 at day 1 PI (Table 1B). Since the peak of TLR induction in young mice from 
our previous experiment was at day 1 PI, only that time point was studied in old mice. CRAMP, 
MDA-5 and mEAR1 were detected at 12 hours and day1 PI and were induced as early as 12 
hours after infection. PTX3 expression was reduced at 12 hours PI and then increased at day 1 PI 
in old mice. 
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 When PRR expression day 1 after infection was compared between old and young mice, 
the expression of CRAMP, MDA-5, mEAR and PDCD-1 were similar in both groups (Figures 
5A and 5B). TLR expression was studied at day 1 PI and the fold change with infection in young 
mice was compared with fold change induced after infection in old mice (Figure 5C). The fold 
change in old mice was lower than the fold change in young mice for TLR1, TLR3, TLR7, TLR8 
and TLR9. 
Age reduces gene expression of PRRs prior to infection. 
 To determine whether aging might alter the baseline expression of genes associated with 
viral recognition, gene expression of PRRs were measured by qPCR in mouse lung tissue from 
old and young mice that were not infected (Figure 5D). Expression of TLRs showed slight 
decreases in TLR 4 and TLR5 with age, and increases in TLR 7 and TLR 8 expression (Figure 
5D), however the magnitude of change was not remarkable. Gene expression for downstream 
signaling proteins IRF3, TRAF6 (p<0.05) and TICAM1 (p<0.1) were lower in old mice (Figure 
5D). 
Influenza infection induces the expression of type I IFN and stimulated genes in young and old 
mice.  
Table 2A and 2B depict the fold change in gene expression of type I IFN and ISGs after 
influenza infection. With respect to Type I interferon and interferon stimulated genes, IFNα2, 
IFNα4, IFNβ1 and 17 ISGs were detected in whole lungs of young mice (Table 2A). Expression 
was seen at early as 6 hours PI for IFNα4, IFNβ1 and several ISGs.  By 12 hours PI, most 
interferon or interferon-inducible genes were highly expressed.   
After infection with influenza, ISGs were detected by qPCR in lungs of old mice at 6 
hours, 12 hours and 24 hours PI (Table 2B). At 6 hours PI, CXCL10, OAS1a, OAS1b and 
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STAT2 mRNA were induced. By 12 hours PI, all ISGs that were detected were higher with 
infection. 
Figures 6A, 6B and 6C show the induction of ISGs with infection in old and young mice 
compared to the respective non infected groups. Infection induces the expression of these genes 
to different intensities, the fold change in old mice being less than fold change with infection in 
young mice. This was evident for genes such as IFNα4, CXCL10, IFNβ1, Mx2, Mx1, ISG15, 
IFIT3 and IFNα2 (Figure 6A) at 6 hours PI. The pattern was still evident at 12 hours PI for 
PTX3, CXCL10, PKR, IFNα4 and Mx2 although the gap between young and old groups was 
decreased (Figure 6B). At 24 hours PI, young and old mice had similar fold changes with 
infection (Figure 6C).   
 In order to compare the mRNA expression in infected old and young mice, the mRNA 
expression from old infected mice were compared with mRNA from young infected mice at the 
same time points (Figures 7A, 7B and 7C). The pattern of gene expression suggested a down-
regulation of ISGs in the old mice at 6 hours PI, such as IFNα4 (q<0.1), CXCL10, IFNβ1, Mx2, 
Mx1, ISG15, IFIT3 and IFNα2 (Figure 7A). At 12 hours PI (Figure 7B), many genes were still 
down-regulated in the old mice, for example IFNβ1 and PTX3 (q<0.05), CXCL10 (q<0.1), PKR, 
IFNα4 and Mx2. By 24 hours PI (Figure 7C) all mRNA had returned to baseline, and OAS1a 
was trending an increase (q<0.1).  
Age reduces gene expression of type I IFN response prior to infection. 
 Gene expressions of ISGs were measured by qPCR in mouse lung tissue from old and 
young mice that were not infected (Figure 7D).  Of the genes that were detected, PTX3 and PKR 
mRNA were decreased by 0.58 fold in old mice compared to young mice. β2-microglobulin and 
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ADAR1 expression was reduced by 1/3 in old mice as compared to young mice, while OAS2 
was increased by 1.8 fold (p<0.05, q<0.1).   
Infection reduces the expression of autophagy related genes in infected young and old mice. 
Genes associated with autophagy were detected at day 1 post infection. After mice were 
infected with influenza, both young and old mice at day 1PI down-regulated the genes involved 
in autophagy machinery and regulation, like Akt1, Atg, Bad, Bcl2, Ulk in infected mice when 
compared to the respective uninfected groups (Table 3). The changes in old mice were similar to 
the fold changes in young mice with infection, indicating that autophagy was similarly regulated 
by infection in old and young mice.  
When genes associated with autophagy were detected in old and young mice prior to 
infection, age was not associated with a significant difference in expression of genes of the 
autophagy pathway in healthy mice. 
Age alters the cell populations in the lungs and BALF of mice.  
Cell populations were detected by flow cytometry in lung tissues as well as cells obtained 
from BAL from old and young mice. Total cell counts in healthy mice were not different in lungs 
(Figure 8A) but in BALF old mice had higher total cell counts than young mice (Figure 8B). Cell 
counts of individual populations also were similar in old and young mice (Figures 8C and 8D). 
The frequency of constitutive monocytes was decreased in lungs and BALF of aged mice (Figure 
8E and 8F).  
 The same cell populations were assessed 24 hours after mice were infected with influenza 
(Figures 8A- 8F). The total cell counts were reduced in BALF of infected old mice when 
compared to infected young mice but not in the lungs (Figures 8A and 8B). The cell counts in 
lungs were lower in infected old mice for pDCs, neutrophils and inflammatory monocytes, but 
53 
 
not for alveolar macrophages and constitutive monocytes which remained unchanged (Figure 
8C). In the BALF, cells displayed the same pattern, with lower pDCs, inflammatory monocytes 
and also NK cell (Figure 8D).  The percentage of inflammatory monocytes was lower in old 
mice in both lungs and BALF, and percentage of neutrophils and pDCs were lower in lungs of 
old mice (Figures 8E and 8F). 
Discussion  
 Most studies on aging have been conducted in vitro or on specific cell types isolated from 
aged subjects. Our experiments were conducted on whole lung homogenates for a more 
comprehensive picture of how the lung tissue changes with age and how that affects the immune 
response to influenza infection, with the cells in their native microenvironment. We have 
presented a study on changes in PRRs, Type I IFN response, autophagy and cell infiltration in 
the lungs in healthy aged and young mice, as well as after influenza infection in aged and young 
mice. This enabled us to identify alterations in these pathways with age and viral infection.  
 Initially, the gene expression studies were performed to identify the anti-viral pathways 
that were induced by infection in young adult mice. The expression of anti-viral genes such as 
TLRs, IFNα2, IFNα4, IFNβ1 and ISGs were induced in young mice as early as 12 hours post 
infection.  As the time course of gene expression was established, experiments were performed 
to determine whether age affected the expression of these genes prior to infection and at multiple 
time points post-infection. Prior to infection, there was no evidence of a significant difference in 
gene expression of PRRs such as TLRs, MDA-5, or innate proteins CRAMP, PDCD1 and 
mEAR1 between healthy old and young mice. A decrease in TLRs from DCs along with reduced 
cytokine production of IL6, TNFα and IFNα from DCs and macrophages have been reported in 
the literature (169, 182, 228). Though the changes in TLRs were not noticeable in our model, the 
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signaling molecules IRF3, TICAM1 and TRAF6 showed a decrease associated with age. 
TICAM-1 is the functional adapter for both TLR3 and TLR4 that induces type I IFN and 
MyD88-independent DC maturation. TRAF6 is a central adaptor molecule in TLR signaling that 
leads to the activation of NFκB, and IRF3 is an Interferon Regulatory transcription factor that 
leads to IFNβ induction. These changes could potentially reduce the functional capacity of the 
TLR pathway. 
 Type I IFN subunits IFNα2, IFNα4 and IFNβ1 were not significantly different between 
old and young mice, but ADAR1, β2m, PTX3 and PKR, all of which have anti-viral properties 
were significantly lower in older mice. OAS2 was the only ISG to be higher in aged mice. These 
data suggest that while PRR expression in whole lung homogenate was not altered with age, 
some anti-viral gene expression may be reduced, leading to an altered immune activation status 
in healthy aged mice. It is interesting that though TLR signaling was down-regulated along with 
IFN inducible genes,  
inflammatory cytokine genes were still up-regulated. This may imply that increased 
inflammation associated with aging is not induced by TLRs but by another pathway, for example 
the inflammasome.   
 We observed higher levels of cytokine mRNA for IL10, IL1β, IL6, TNF and IFNγ in 
lungs of healthy aged mice, which may be indicative of the increase in basal levels of 
inflammation that are a hallmark of old age. Other studies have also noted increased cytokines 
such as IL6 in baboons (144) and IL12p70, IL1β, TNFα, IL6, and IL10 in humans (8). Increased 
mRNA expression of chemokines CCL2 (MCP-1), CSF2 (GM-CSF) and CXCL10 (IP-10) may 
also contribute to “inflammaging” by attracting monocytes and dendritic cells to the lung tissue. 
55 
 
These changes in chemokines may change the trafficking of stem cell populations being attracted 
to the lungs.  
 Post influenza infection, influenza viral load was higher in lungs of old mice at days 3 
and 8 PI, but lower at 24 hours PI (when given a lethal dose). We have previously reported that 
old mice had lower viral titers in lungs 6 hours PI and in BAL collected at 12 hours PI, as 
compared to young mice, and other groups have noted a delay in viral clearance in aged mice 
lungs but decreased viral titer in aged mice from day 2 PI (222). PRRs such as TLRs 1, 2, 3 and 
9, MDA-5, mEAR1 and PTX3 were induced in old mice at day 1 PI. The increase in PRR gene 
expression post influenza infection was lower for old mice as compared to the increase in young 
mice. These include TLRs 2, 3, 6, 7, 8 and 9. Many inflammatory and activation markers such as 
IL1b, TNF, CCL2, IL6, CD80/86 and Ly86 were induced to a lesser extent in the old mice. This 
pattern is consistent with the decrease in viral titer at day 1 post infection when compared to 
young mice. ISGs were induced post infection in old mice, but the activation seemed to be 
delayed in old mice early after infection.  
 The cell populations that were studied in lungs and BALF suggested that immune cells 
such as inflammatory monocytes and pDCs move from the BALF into the lungs as early as day 1 
post influenza infection. However, we noted reduced numbers of pDCs, neutrophils and 
inflammatory monocytes associated with aging in both BALF and lungs of infected mice. Taking 
all our data into account, it is possible that in our model the decreased amount of virus in lungs at 
early time points after infection (6, 12 and 24 hours PI) led to lower immune activation that was 
observed in old mice.  
 Autophagy has been associated with increased antigen presentation and yet it is required 
for some viruses during replication, while assembling virus particle near the cell surface inside 
56 
 
the cytosol (45, 179, 202). We found that autophagy was decreased at day 1 post infection with 
influenza in both young and old mice in a similar fashion. This could either be a defense 
mechanism of the body against the virus to minimize replication, or an evasion strategy of the 
virus to minimize antigen presentation. More studies would have to be carried out to determine 
the significance of this finding, but since this is quite early in infection, the possibility exists that 
this may be a host defense mechanism to minimize replication. While some groups have reported 
decreased autophagy function with aging (34), our data did not provide any evidence of a 
significant difference in autophagy related genes prior to infection in old mice.  
 In conclusion, we observed that viral load is lower in lungs of old mice as compared to 
young mice, suggesting that viral uptake into cells may be impaired with age. Consequently, we 
noted reduced immune activation at early time points post infection (6, 12 and 24 hours post 
infection) along with decreased cellular infiltration into lungs associated with aging. However, 
higher viral load at days 3 and 8 post infection suggest that viral replication is not impaired later 
in infection but the immune response, perhaps because of delayed immune activation early in 
infection, is not able to clear the virus as efficiently as young mice. Even though healthy aging 
was associated with higher levels of inflammatory cytokine mRNA prior to infection, the fold 
change of mRNA for activation and inflammatory markers at day 1 post infection were lower in 
old mice. This study provides further evidence for immune impairment with aging. It highlights 
the importance of elucidating the mechanisms of immunosenescence in order to provide 
therapeutics and vaccinations that are tailored to support and augment the immune response in 
the elderly. 
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Figures for Chapter 2 
Figure 1  
 
 
Figure 1: Body weight loss over time was assessed for a time by age interaction, determined by 
mixed ANOVA. (t*a) signifies a significant time by age interaction; p < 0.05) 
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Figure 2A.  
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Figure 2B.  
 
 
Figure 2A – 2B: Viral load in lungs of young and old mice infected with influenza virus. 2A) 
Viral load in BALF and lungs at day 1 post influenza infection. 2B) Viral load in lungs at day 3 
and day 8 post influenza infection. Viral load was detected by quantitative PCR for influenza NP 
protein. * indicates a significant (p<0.05) effect of age.  
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Figure 3A. 
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Figure 3B. 
 
 
Figure 3A – 3B: Viral load in lungs comparing a group of old mice and a group of young mice 
that were infected with 1:25000 dilution of influenza virus (labeled dose 1). Another group of 
young mice was infected with a 1:50000 dilution of influenza virus (labeled dose 2). 3A) Viral 
load in lungs of mice at day 3 post influenza infection. 3B) Viral load in lungs of mice at day 8 
post influenza infection. Viral load was detected by quantitative PCR for influenza NP protein. * 
indicates a significant (p<0.05) effect of age, Old Dose 1> Young Dose 1 AND Dose 2. 
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Figure 4A.  
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Figure 4B. 
 
 
Figure 4A – 4B: Effect of age on mRNA expression of genes associated with inflammation. 
Gene expression was detected in whole lung homogenates of mice using quantitative Real Time 
PCR. (4A) Whole lung homogenates were obtained from uninfected mice. Fold changes were 
calculated by comparing old uninfected mice to young uninfected mice. * indicates a significant 
effect of age (q value<0.05), + indicates trend (q value <0.1, p value <0.05). (4B) Fold changes 
in young mice with infection depicted alongside fold change in old mice in the same genes at day 
1 post influenza infection.  
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Table 1A.  
Fold change with infection in young mice 
 
Gene name 12 hours PI Day 1 PI Day 2 PI Day 4 PI 
Tlr1 3.107 3.8145 3.9145 4.3334 
Tlr2 2.7784 4.9712 3.813 3.3425 
Tlr3 3.3931 7.1697 4.1008 2.041 
Tlr4 1.4872 1.9479 1.6312 1.5503 
Tlr5 0.6669 0.612 0.7264 0.0731 
Tlr6 2.2302 2.955 2.0569 2.4631 
Tlr7 2.3882 5.5735 4.5607 3.791 
Tlr8 1.5656 2.9202 2.3082 2.1586 
Tlr9 3.1704 17.3156 8.464 11.5354 
Myd88 2.8939 6.707 4.0549 2.7504 
 
Clec4e 13.6785 28.1781 19.8422 16.9182 
PTX3 0.998774 5.452357 
CRAMP 1.801402 1.679416 
PDCD1 0.800681 4.746421 
MDA5 2.816064 4.657481 
mEAR1 1.513176 1.71335 
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Table 1B.  
Fold change with infection in old 
mice 
Gene name Day 1 PI 
Tlr1 2.1053 
Tlr2 4.5083 
Tlr3 3.0149 
Tlr4 2.1502 
Tlr5 1.0381 
Tlr6 1.9392 
Tlr7 1.7726 
Tlr8 1.3302 
Tlr9 2.7615 
Myd88 5.5963 
12 hours PI Day 1 PI 
CRAMP 2.82619 2.58433 
PDCD1 1.19322 4.51479 
MDA5 2.30121 7.2383 
mEAR1 1.57507 1.92564 
PTX3 0.5783 4.60359 
 
Table 1A – 1B: Whole lung homogenates were tested for mRNA expression by quantitative Real 
Time PCR. (1A) Fold change in gene expression of PRRs at 12 hours, day 1, day 2 and day 4 
post influenza infection in young mice as detected by Real Time PCR. (1B) Fold change in gene 
expression of PRRs at 12 hours and day 1 post influenza infection in old mice. Fold change 
numbers in bold font indicate significance (p<0.05) and fold change numbers in italics indicate 
(0.05< p <0.1) 
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Figure 5A. 
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Figure 5B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
1    
2    
4    
8    
CRAMP PDCD1 MDA5 mEAR1 PTX3
F
o
ld
 c
h
a
n
g
e
 I
n
fe
ct
e
d
/N
o
n
 I
n
fe
ct
e
d
 (
lo
g
-
2
 s
ca
le
)
Infection in young and old mice at day 1 PI
24 hrs p.i.  Young
24 hrs p.i.  Old
68 
 
Figure 5C.  
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Figure 5D.  
 
 
Figure 5A – 5D: Gene expression was detected in whole lung homogenates of mice using 
quantitative Real Time PCR. (5A) Fold changes in young mice with infection depicted alongside 
fold change in old mice in the same genes at 12 hours and (5B) at day 1 post influenza infection. 
(5C) Fold changes in TLR expression at day 1 post infection for young mice are shown alongside 
fold change in old mice in the same genes. (5D) Whole lung homogenates from uninfected mice 
and were tested for mRNA expression of TLR and TLR signaling proteins. For all figures, * 
indicates a significant effect of age (q value<0.05), + indicates trend (q value <0.1, p value 
<0.05). 
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Table 2A.  
Fold change with infection in young mice 
 
Gene Name 6 hours PI 12 hours PI 24 hours PI 
 
IFNa2 0.476111 3.635415 14.13823 
IFNa4 36.1449 459.4614 1310.153 
IFNb1 21.34328 329.9881 648.1662 
ADAR1 1.280263 1.690137 2.718423 
B2m 0.633374 0.526717 1.905104 
Bst2 1.30154 4.572585 15.03247 
CXCL10 11.96891 174.8919 620.8668 
Eifak2 1.348551 4.968878 7.037485 
Gbp1 0.925914 3.256382 9.695532 
Ifi204 1.024202 5.575379 18.46652 
Ifit1 2.948375 12.4983 29.36407 
Ifit3 1.043333 8.4088 21.55738 
Irf7 1.259962 6.9105 32.27533 
Isg15 2.77612 5.62452 13.62401 
Mx1 2.946067 29.01084 50.04521 
Mx2 5.863207 51.27771 96.01847 
Oas1a 4.755872 26.1348 37.75746 
Oas1b 305.975 630.5164 1366.282 
Oas2 3.124878 5.057975 15.47245 
Stat2 2.442435 2.463723 6.061984 
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Table 2B.  
Fold change with infection in old mice 
 
Gene name 6 hours PI 12 hours PI 24 hours PI 
IFNa2 0.388 3.48568 21.63747 
IFNa4 3.205679 109.5822 1249.392 
IFNb1 6.711894 97.82017 674.8158 
ADAR1 2.218431 4.332621 10.77458 
B2m 1.128894 2.115414 4.76531 
Bst2 0.747207 3.367762 19.75067 
CXCL10 7.0675 117.7253 989.8733 
Eifak2 1.736726 5.209266 17.34515 
Gbp1 0.668037 2.119582 9.040797 
Ifi204 0.499529 3.290918 18.12501 
Ifit1 1.964075 13.90633 49.35006 
Ifit3 0.727929 9.66326 39.22115 
Irf7 0.512112 2.71912 18.36427 
Isg15 1.372542 3.766097 10.94242 
Mx1 1.202794 16.17283 53.33608 
Mx2 1.534916 23.7789 73.43368 
Oas1a 3.407964 20.29778 56.73787 
Oas1b 130.3367 312.9894 632.9291 
Oas2 1.048212 1.98686 10.39278 
Stat2 1.773587 2.189771 6.19511 
 
Table 2A – 2B: Whole lung homogenates were tested for mRNA expression by quantitative Real 
Time PCR. (2A) Fold change in gene expression of Type I IFN and ISGs at 6 hours, 12 hours 
and 24 hours post influenza infection in young mice and (2B) in old mice are shown. Fold 
change numbers in italics indicate significance (p<0.05).  
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Figure 6A.  
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Figure 6B.  
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Figure 6C. 
 
 
Figure 6A – 6C: Infection induces type I IFN subunits and ISGs in young and old mice to 
different levels. Gene expression was detected in whole lung homogenates of mice using 
quantitative Real Time PCR. Fold changes in young mice with infection depicted alongside fold 
change in old mice in the same genes at (9A) 6 hours, (9B) 12 hours and (9C) day 1 post 
influenza infection. 
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Figure 7A. 
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Figure 7B.  
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Figure 7D.  
 
 
Figure 7A –7D: Effect of age on mRNA expression of type I IFN and ISGs in infected mouse 
lung homogenates. Whole lung homogenates were obtained from mice infected with influenza 
and tested for mRNA expression by quantitative Real Time PCR. The fold changes presented 
were calculated as the fold change of old mice compared to young mice at the same time point 
post infected. This was calculated and comparisons are presented for (10A) 6 hours, (10B) 12 
hours and (10C) 24 hours post infection. * indicates a significant effect of age (q value<0.05), + 
indicates trend (q value <0.1, p value <0.05). (7D) Whole lung homogenates were obtained from 
uninfected mice and were tested for mRNA expression of ISGs. For all figures, * indicates a 
significant effect of age (q value<0.05), + indicates trend (q value <0.1, p value <0.05). 
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Table 3.  
Gene 
Name 
 
Young Infected 
Day 1 pi 
 
Old 
Infected 
Day 1 PI 
 
Akt1 0.2509 0.3705 
App 0.3771 0.49 
Arsa 0.2974 0.2572 
Atg16l1 0.5755 1.8671 
Atg3 2.2197 1.8088 
Atg4d 0.3271 0.2761 
Atg5 0.5416 0.8731 
Atg7 0.1832 0.2486 
Atg9a 0.2109 0.2585 
Atg9b 0.2699 0.2114 
Bad 0.3704 0.3716 
Bcl2 0.3588 0.2532 
Ctsb 3.1481 2.0658 
Ctss 5.2006 2.6604 
Eif4g1 0.3307 0.559 
Fas 1.7486 1.0216 
Gaa 0.5163 0.7518 
Hgs 0.3575 0.4827 
Hspa8 2.3287 2.1962 
Htt 0.2045 0.1582 
Irgm1 10.5768 3.8996 
Map1lc3a 0.2896 0.409 
Mapk14 0.4992 0.596 
Pik3cg 0.3152 0.3181 
Tgfb1 0.5292 0.5606 
Trp73 0.2813 0.2752 
Ulk1 0.2069 0.1949 
Ulk2 0.2482 0.4258 
 
Table 3: Fold change in mRNA expression of genes associates with autophagy pathway in young 
and old mice at day 1 PI. Whole lung homogenates were tested for mRNA expression by 
quantitative Real Time PCR. Fold change numbers in bold font indicate significance (p<0.05) 
and fold change numbers in italics indicate (0.05< p <0.1). 
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Figure 8A. 
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Figure 8B. 
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Figure 8C 
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Figure 8D 
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Figure 8E 
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Figure 8F 
 
 
 
Figure 8A – 8F: Cell populations were detected in BALF and lungs of mice using flow 
cytometry. Total numbers of live cells are shown in (8A) lungs and (8B) BALF of uninfected 
mice and infected mice at day 1 post influenza infection. (8C) shows the cell counts of 
inflammatory monocytes, neutrophils, DC, pDC, constitutive monocytes and alveolar 
macrophages in the lungs of mice and (8D) shows cell counts for inflammatory monocytes, DC, 
pDC and alveolar macrophages in BALF of mice. Cell frequencies were calculated as the 
percentage of total live cells for each population. (8E) shows the cell frequencies of 
inflammatory monocytes, neutrophils, DC, pDC, constitutive monocytes and alveolar 
macrophages in the lungs of mice and (8F) shows cell frequencies for inflammatory monocytes, 
DC, pDC and alveolar macrophages in BALF of mice. Statistical significance was determined by 
one-way ANOVA, * indicates a significant effect of age (p value<0.05), + indicates trend (0.05< 
p <0.1). 
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Abstract 
 Physical activity may have a beneficial effect on the immune response to pathogens and 
infections in aged immune systems that exhibit immunosenescence. The potential impact of 
exercise on expression of pathogen recognition receptors (PRRs) and type I interferon (IFN) 
response, as well as cell populations in the lungs were examined in aged exercised (EX) mice 
compared to aged non exercised (NON-EX) mice. In previous findings, an exercise-associated 
reduction of lung viral load was observed in aged exercised-treated mice that were infected with 
influenza virus as compared to aged non-exercised mice. It is possible that early host innate 
defenses are altered by exercise training and result in decreased viral load.  To test this 
hypothesis, aged BALB/c mice (17 months of age) were exercised at a moderate intensity 
5d/week for 10 weeks. Twenty-four hours after the last exercise session, mice were infected with 
influenza A/PR/8/34 virus through an intranasal route. NON-EX old mice and young mice (2 
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months of age) were infected at the same time. Lungs and bronchoalveolar lavage fluid (BALF) 
were collected prior to infection and at multiple time points post-infection (PI). The mRNA for 
several PRR’s, interferon, and interferon-stimulated genes was detected in whole lungs using 
Real Time PCR. Ciliary beat requency was measured to examine the effect of exercise on 
mucociliary clearance in exercised mice. Cell populations were studied in lungs and BALF by 
flow cytometry.  In non-infected mice, exercise training resulted in greater levels of expression 
of TLR 6, 7 and 8,  as well as β2m, a component of MHC class I molecules, and GBP1 (a Type I 
IFN stimulated gene) in whole lung tissue. Lungs of exercise mice had increased numbers of the 
following cell populations: constitutive and inflammatory monocytes, plasmacytoid dendritic 
cells (pDCs) and neutrophils.  In the BALF, plasmacytoide dendritic cells (pDCs ) also tended to 
be found in greater numbers. These effects of exercise were no longer observed 24 hours post-
infection with influenza virus. There were no differences in the total number of lung cell sub-
populations between exercise and non-exercise mice 24 hours after infection with influenza virus 
although the percent change relative to pre-infection was different.  Also, viral load was 
decreased in the respiratory tract of EX mice.  Our results suggest that exercise may alter the 
time course of interferon-inducible genes such that exercise mice respond more quickly (6 hrs 
post-infection) relative to non-exercised mice.  Taken together these exercise-associated changes 
may contribute to an early reduction in lung viral load.   
Introduction 
 Influenza and influenza related secondary infections cause severe disease, 
hospitalizations and mortality each year (35). Some groups in the population are more prone to 
influenza infections, for example pregnant women, young children, elderly individuals and 
immunocompromised patients (124, 220). Although influenza vaccination  may reduce 
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hospitalization rates in the elderly (15), the response to vaccines declines in aged individuals 
leaving them more susceptible to infection. These factors makes the prevention of infectious 
diseases in the aging population more challenging (13). 
 Many lifestyle factors are proposed to affect risk of infection and vaccine responses in 
older individuals, exercise being a key intervention (14, 113, 114). Moderate exercise may slow 
down or even reverse the detrimental effects of age on the immune system, as demonstrated in a 
number of studies on humans and mouse models. Exercise reduces the mortality and morbidity 
in influenza or influenza associated infection in mice and humans (14, 200, 237). In aged 
subjects, exercise may improve the response to vaccinations (111, 113, 240).  However, the 
mechanism by which exercise decreases morbidity and mortality in respiratory infections in the 
elderly remains largely unknown, and the role of early host defenses have not been elucidated.   
 Physical activity of moderate intensity, but not low or high intensity, decreases the risk of 
upper respiratory tract infections, as proposed by Nieman as the “J” curve hypothesis (155, 160). 
Moderate exercise decreases mortality in influenza infections in mice (138) and improves 
antibody response to HSV-1 infections in mice (116) and responses to influenza vaccine in 
elderly human subjects (111, 240).  Some data suggests that exercise may reverse some age 
related changes of immunity such the age-related decline in IL-2 production, and may restore the 
Th1 response that is reduced with age (201). Exercise may also reduce inflammation in the 
elderly (also known as “inflammaging”), though this is still disputed by conflicting studies (201).  
Much of the work on exercise and immunosenecence has been focused on T cells responses, and 
exercise may alter T cell proliferation, activation marker expression including CD28, as well as 
IL2 production and Th1/Th2 balance.  Limited work has examined the impact of exercise on the 
innate response to infections, although several studies have used other non-infectious disease 
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models to address the role of exercise in modulating innate host defense.  For examples, some 
data suggests that exercise may alter the composition of cell subsets, particularly NK cells and 
monocytes (214, 221, 243). Neutrophil phagocytosis was reported to be increased with exercise 
in obese aged individuals (150). Exercise was reported to reduce TLR4 expression in PBMCs of 
elderly women in two studies (55, 146).  Although these findings provide some insight into the 
potential impact of exercise on innate immunity, the response to a live pathogen may be more 
predictive of whether exercise can be effective in reducing infection severity.   
 In response to viral infection, innate pattern recognition receptors such as the toll like 
receptors (TLRs) may stimulate Type I IFN (IFNα and IFNβ) production by plasmacytoid 
dendritic cells (pDCs), alveolar macrophages and infected epithelial cells (100). IFNα/β render 
an anti-viral state to the cells by inducing the transcription of several IFN stimulated genes 
(ISGs) that have direct or indirect antiviral properties (36). To our knowledge, no other studies 
have reported the effect of regular physical activity (or chronic exercise) on pathogen recognition 
receptors including TLRs, or the type I IFN response to influenza virus infection. Therefore the 
complete effects of exercise on the different facets of the immune response remain to be defined. 
Further insight into the innate system will help in revealing the interactions between the innate 
and adaptive responses with physical activity and designing lifestyle changes as well as possible 
molecular or mechanistic targets for improving the response to infections in the elderly.   
 The purpose of this study was to evaluate the Type I IFN response, TLR pathway and 
cellular composition of the lungs after exercise training, and to explore the mechanism by which 
exercise alters the response to influenza virus in aged mice. The innate recognition proteins were 
detected using quantitative Real Time PCR on lungs of physically active and inactive mice, and 
flow cytometry was used to detect cell composition of lungs and bronchoalveolar lavage fluid 
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(BALF) from the same mice. The effects of exercise, if any, on the immune response to 
influenza infection can help in designing lifestyle changes that may improve disease outcome in 
the elderly.   
Materials and Methods 
Animals and exercise procedure 
 Aged male BALB/c mice (17 months of age) were obtained from Charles River (aged 
NIA colony) and randomly assigned to the following groups: Old, exercised (EX) and old, non-
exercised (NON-EX). The mice in the EX group were exercise-trained on a treadmill for 9-10 
weeks. Exercise duration was gradually increased during weeks 1 to 4; from weeks 5 to 8, mice 
ran 40–45 min/day; then 45 min/day for the remainder of the training period. The speed was 
progressed from 8 m/min during week 1 to 18 m/min by week 8. The NON-EX group did not 
exercise. All animal procedures were approved by the Institutional Animal Care and Use 
Committee (IACUC). 
Virus and Infection 
 Twenty-four hours after the last exercise session, mice were anesthetized using 
aerosolized isoflurane and infected via an intranasal route with influenza virus strain A/PR/8/34 
(H1N1) at a dose of 163.84 HA units per mouse (stock virus – HAU= 1024/0.05mL or 
10^9.5/mLEID50 diluted 1:6.25, 1:25,000 and 1:50,000 in sterile saline). Non-infected controls for 
each group were housed separately from the infected mice. Mice remained in their cages and did 
not exercise after infection (n = 6 to 10). 
Tissue collection  
 Mice were euthanized by cervical dislocation at 6 hours post infection (PI), 12 hours PI, 
and 24 hours PI Lung lobes were collected and used to determine viral load. Remaining lung 
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tissue was collected for RNA isolation and flow cytometry. Bronchoalveolar lavage fluid 
(BALF) was collected by inserting a catheter attached to a syringe through an incision in the 
trachea, and airways were flushed three times with 1 mL of PBS. The BALF was centrifuged, 
cells were collected for analysis by flow cytometry, and the supernatant was stored at -80°C until 
subsequent analysis could be carried out by Multiplex 32-plex (Millipore) plates on the Luminex 
200 system (BIO-RAD).  RNA was isolated using TRIzol Reagent (Invitrogen, Carlsbad, 
California).  Lung RNA was further purified using the RNeasy Kit (QIAGEN, Valencia, 
California) then frozen at -80°C until further testing was carried out by PCR. 
qPCR and PCR Microarray 
 1000 ng of purified lung mRNA was analyzed for interferon inducible gene expression 
using the 96-well Mouse Toll Like Receptor Pathway RT² Profiler™ PCR Array 
(SABiosciences, Frederick, Maryland) and protocol provided with the array (n = 3 to 8). Samples 
were analyzed using the BioRad MyiQ and corresponding MyiQ Optical System Software 
Version 1.0. For analysis of the interferon-stimulated genes (ISGs), customized primers were 
designed using Primer Express software and obtained from Applied Biosystems. GAPDH, beta 
actin and beta galacturonidase were used as the reference housekeeper genes (n = 6 to 10). 
Identification of Lung Cell Populations by Flow Cytometry 
 Cell populations were determined in lungs and BALF from uninfected EX and NON-EX 
mice and infected mice that were euthanized on day 1 PI (n = 8 to 10). Live cells were gated by 
comparing forward scatter with side scatter and deselecting the cells with low forward and side 
scatter. Lungs were homogenized in collagenase containing media and single-cell suspensions of 
lungs were obtained using a 40µm cell strainer. Alveolar macrophages (Highly autofluorescent, 
CD11c high, CD11b low, Gr1 negative), constitutive monocytes (CD11b positive, Gr1 negative), 
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pDCs (CD11b low, CD11c intermediate, mPDCA positive, low autofluorescence), neutrophils 
(CD11c negative, CD11b positive, Gr1 high, high side scatter) and inflammatory monocytes 
(CD11b positive, Gr1 high, CD11c negative, low side scatter) were identified in cells obtained 
from whole lung homogenate and BAL. Flow cytometry was performed using a FACSCanto 
flow cytometer. FlowJo 7.6 software was used for gating and analysis. 
Determination of viral titer 
 Mice were euthanized at multiple time points post-infection and viral load was assessed 
in the lungs. Virus titers were measured by a quantitative fluorogenic reverse transcription-
polymerase chain reaction (real-time RT-PCR) using TaqMan® chemistry.  Using sequences 
deposited in GenBank (http://www.ncbi.nlm.nih.gov/Genbank/index.html) and Influenza 
Sequence Database (http://www.flu.lanl.gov), virus-specific oligonucleotide primers and a 
fluorescent probe were engineered to target a highly-conserved region of SIV NP gene.  The 
forward primer (SIVRTF:  5’- CGGACGAAAAGGCAACGA-3’) and reverse primer (SIVRTR: 
5’- CTGCATTGTCTCCGAAGAAATAAG-3’) were synthesized by a commercial vendor 
(Integrated DNA Technologies, Coralville, IA, USA).  An TaqMan® MGB probe with a 5’ 
reporter 6-carboxyfluorescein (FAM) and a 3’ non-fluorescent quencher (SIVRTP: 5’-6FAM- 
CCGATCGTGCCYTC) was synthesized by Applied Biosystems (Foster City, CA, USA).  To 
conduct the assay, viral RNA was first extracted from 50 µl of lung sample, positive control 
(H1N1 and H3N2 swine influenza viruses) and negative control (elution buffer) using the 
Ambion® MagMAX™ Viral RNA Isolation Kit (Applied Biosystems) and KingFisher® 96 
magnetic particle processor (Thermo Scientific, Waltham, MA, USA).  Real-time RT-PCR was 
then carried out with the QuantiTect® Probe RT-PCR Kit (Qiagen, Valencia, CA, USA) in a 20 
µl reaction volume using 4 µl of extracted template.  Primers were added at a final concentration 
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of 0.4 µM each and the probe was at a final concentration of 0.2 µM.  The PCR amplification 
was performed on the ABI 7900HT Sequence Detection System (Applied Biosystems, Foster 
City, CA, USA) with the 384-well format.  Cycling conditions were as follows:  a) reverse 
transcription for 30 min at 50° C; b) a 15 min activation step at 95° C, and c) 40 cycles of 15 sec 
at 94° C and 60 sec at 60° C.  A set of influenza preparations, each with a known virus titer 
(EID50/ml), were used to generate a standard curve.  Samples with threshold cycles (Ct) ≤35 
were considered positive.  The amount of influenza in each sample was calculated by converting 
the Ct value to a virus titer using the standard curve. 
Statistical Analysis 
 Statistical analysis was performed using SPSS Statistics 17.0. A one-way ANOVA was 
used to compare lung and BAL cell populations between young and old mice. Viral load data 
was log transformed prior to analysis.  Statistical trends were denoted by p<0.1 and significance 
levels for all tests were set at p<0.05. The false discovery rate was calculated as the q value for 
PCR results. Statistical trends were denoted by q <0.1 and significance levels were set at q<0.05. 
Results 
Exercise treatment induces expression of ISGs and TLRs 
 In order to determine whether exercise alone without infection may impact Type I IFN 
gene expression and/or expression of genes considered to be downstream of IFN, qPCR was 
performed on mouse lung tissue collected from EX and NON-EX mice (Table 1, Figure 1). Lung 
tissue was collected 24 hours after the last exercise session and the results showed that exercise 
increased the expression of  β2m (β2-microglobulin) and GBP1 (Guanylate Binding Protein) 
with a trend towards upregulation of  ADAR1, PKR (Eifak2 or Protein Kinase R), BST2 and 
CXCL10.  Though several genes downstream of type I IFNs were upregulated, IFNα2, IFNα4, 
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IFNβ1 and transcription factors IRF7 and STAT2 were either decreased (IFNα2 was reduced 
significantly) or remained unchanged (IFNα4 and STAT2).  
 Lung TLR expression was measured by PCR microarray (Figure 2).  Exercise treated 
aged mice expressed higher amounts of TLR3 (p= 0.057), TLR6, TLR7 and TLR8 (p < 0.05). 
TLR9 was also increased approximately 2 fold but not significantly (p = 0.39). 
Exercise reduces influenza viral load in aged mice  
 In order to determine if the observed changes in gene expression may be associated with 
reduced viral load following intranasal challenge with influenza, EX and NON-EX mice were 
infected with influenza (24 hours after the last exercise session).  One day post-infection viral 
load was measured by qRT-PCR in lungs and BALF collected from mice (Figure 3). The log of 
viral load was compared between groups. Exercise reduced the viral load in BALF of old mice 
(p<0.05) and lungs (p=0.42) 
Exercise may alter the time course of ISG expression in response to influenza infection, but does 
not alter TLR expression at day 1 post infection 
 After EX and NON-EX mice were infected with influenza virus, ISGs were detected in 
the lungs by qRT-PCR at 6 hours, 12 hours and 24 hours PI (Figures 4A, 4B and 4C). To 
evaluate the effects of exercise, gene expression in EX infected mice was compared to NON-EX 
infected mice at the same time point.  At 6 hours PI, the pattern suggested a general upregulation 
of ISGs in the EX mice relative to the NON-EX mice.  However, by 12 and 24 hours post-
infection, the majority of genes were expressed at similar levels in EX and NON-EX mice.  
TLRs gene expressions were measured only at 24 hours PI (Figure 5) using qRT-PCR.  There 
were no significant differences in TLR expression between EX and NON-EX mice at this time 
point. 
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Exercise reduces the concentration of cytokines and chemokines in aged mice  
 Cytokine and chemokine concentrations were measured in BALF of EX and NON-EX 
mice 24 hours after infection with influenza virus (Table 2). We detected reduced pg/ml 
concentrations of IL-1b, IL-2, IL6, KC, IP10 (p<0.07), and others such as G-CSF, IL-1a, IL2, 
IL10, MCP1, MIG, MIP-1a, MIP1b, MIP2, RANTES, TNFα and VEGF were also decreased 
with EX, though they were not significant.  
Exercise does not alter mucociliary clearance in aged mice 
 Ciliary beat frequency (CBF) was measured in tracheas from EX and NON-EX mice to 
test if the mucociliary escalator is altered with exercise. Tracheas from EX and NON-EX mice 
were collected and stimulated with the beta-agonist isoproterenol to stimulate ciliary beat 
frequency in epithelial cells. Ciliary beat frequency (CBF) was quantified per minute and 
represented in Figure 6. Although aged mice had reduced CBF relative to young mice, EX 
treatment did not restore CBF.   
Exercise alters cell populations in mouse lungs and BALF 
 The total number and frequency of multiple immune cell sub-populations were detected 
by flow cytometry in lung tissues as well as cells obtained from BALF from EX and NON-EX 
mice.  Cell population number and frequency was assessed prior to infection in mice as well as at 
one day post-infection.  Cells were collected 24 hours after the last exercise session in non-
infected mice. The number of cells was increased in the BALF and lungs of non-infected EX 
mice compared to non-infected NON-EX mice (Figures 7A and 7B). Cell numbers were 
increased for alveolar macrophages, constitutive and inflammatory monocytes, dendritic cells 
and neutrophils in lungs of EX mice (Fig 7C).  In the BALF, plasmacytoid dendritic cell (pDC) 
cell numbers showed a trend towards an increase with exercise (Fig 7D).  The percentage of the 
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cell populations in the lungs were assessed by the frequency of immune cells in EX and NON-
EX mouse lungs and BALF (Figs 8A and 8B). Exercise led to the increase in frequency of 
constitutive and inflammatory monocytes, dendritic cells and neutrophils in lungs of EX mice, 
though this did not change in BALF of the same mice. 
Infection after exercise training alters cell populations in lungs and BALF 
 The total number and frequency of BALF and lung cell populations was assessed 24 
hours post-infection. The initial difference in total cell counts between healthy uninfected aged 
EX and NON-EX mouse lungs and BALF was no longer observed post infection (Figures 7A 
and 7B). While cell counts for constitutive monocytes remained increased in lungs of EX mice 
24 hours PI (as compared to infected NON-EX mice at 24 hours PI), none of the other cell 
populations in lungs or BAL were different with exercise (Figures 7C or 7D).  As before, the 
percentages of immune cells infiltrating the lung were calculated in lung tissue as well as BALF 
(Figs 8A and 8B). The frequency of constitutive monocytes was increased with exercise in the 
lung (p<0.05) (as compared to infected NON-EX mice at 24 hours PI). In BAL, the percentage 
of inflammatory monocytes was reduced, but pDC and DC percentages were higher in EX mice.  
Discussion 
 While exhaustive or intense exercise is detrimental for the immune response and 
increases the risk of infection, especially upper respiratory tract infections in athletes (155), 
moderate exercise has shown some benefits in young subjects. Most studies have elucidated the 
effects of acute exercise on the immune response to pathogens. Even less is known about how 
chronic, moderate exercise (that can mimic an active lifestyle in older adults) changes immune 
response and function. Although chronic exercise has been shown to have no effect in some 
disease models (142), we have previously reported that exercise reduces the influenza viral titer 
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and decreases sickness severity in mice (199). The purpose of this study was to determine the 
effects of moderate intensity chronic exercise on innate immunity of the lungs in healthy and 
influenza infected aged mice. 
 Aging is associated with immunosenescence – an impairment of the immune response to 
various stimuli. Loss of TLRs and their function have been reported (54, 117, 145, 182, 228) and 
many cell types are reported to be reduced in numbers and function. We discovered that in our 
model of uninfected aged mice, exercise may improve anti-viral host defenses due to the 
increases in gene expression of TLRs, β2-microglobulin, BST2 and GBP1 in lungs of healthy old 
mice. β2m is a component of MHC-I molecule and GBP1 is IFNγ-inducible and has anti-viral 
properties, though the mechanism has not been elucidated yet (9, 36). However, IFNα2 was 
reduced. Another study also found β2m to be increased in the liver of mice that were physically 
active/ exercised (215). 
 Total cell counts in the lungs and BALF were also higher in exercise mice, including a 
higher percentage of monocytes (constitutive and inflammatory), neutrophils and pDCs in the 
lungs. The increase in the total number of cells and pDCs could explain the increase in 
constitutive proteins such as TLRs, β2m and BST2. TLRs and β2m (as a component of MHC-I) 
are present constitutively on various nucleated cells. pDCs express constitutive levels of TLR7 
and TLR9, and also the antiviral protein tetherin that is encoded by the BST2 gene (which is also 
constitutively expressed on plasma cells and mature B cells) (127). Lower TLR4 and CD16 
expressions without any change in LPS stimulated cytokine production have been reported in 
exercise trained human subjects (54, 145), while natural killer (NK) cell activity was increased 
(147). However, these studies were carried out ex vivo with peripheral blood mononuclear cells, 
while our results represent whole lung tissue from treated mice. To our knowledge, there are no 
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other studies that have reported changes in immune cell infiltration in lungs with exercise in 
uninfected healthy aged mice.   
 When viral load was measured in mice day 1 post infection, exercise decreased the viral 
load in lungs and BALF. This is consistent with our previous studies (199) and shows that the 
exercise-associated decrease in viral titer occurs early in the course of infection. However, at this 
same time point (1 day post-infection) the gene expression of TLRs and ISGs was not different 
between exercise and non-exercise mice. Only OAS1a was decreased in exercise mice when 
compared to non-exercise infected mice. Exercised mice had lower concentrations of cytokines 
such as IL-1b, IL-2, IL6; KC, IP10 and other chemokines as well. The total cell counts were also 
similar in both groups post infection, with a slight reduction in (frequency of) inflammatory 
monocytes with exercise. Only the number and percentage of constitutive monocytes were 
increased in exercise mice. These findings may suggest that exercise training minimizes the 
inflammatory response to infection given that EX mice had a reduced number of inflammatory 
monocytes recruited to the lungs 24 hours post infection and maintained a greater number of 
constitutive monocytes.  
 When type I IFN response was measured earlier in infection, the pattern of gene 
expression suggested an increase in ISGs at 6 hours post infection. Interestingly, IFNα4 was 
decreased at 6 hours post infection in exercise mice and decreased further, along with IFNα2 and 
IFNβ1 at 12 hours post infection, and then returned to baseline levels at 24 hours post infection. 
The pattern suggests that exercise may cause an up-regulation in the innate defense proteins even 
earlier than expected, possibly prior to 6 hours post infection. Others have reported reduced total 
cellular infiltration in lungs of influenza infected mice at days 3 and 5 post infection, decrease in 
IFNγ gene expression, shift in the expression of cytokines in the lung from a Th1 to a Th2 
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response and reduction in influenza M1 protein mRNA expression (137). However, the 
differences between the findings can be explained by the different exercise regimes utilized by 
the two groups, which could have a significant effect on the response to infection. 
 Since there was no difference between ciliary beat frequency of exercise and non-
exercise mouse tracheas, we concluded that mucociliary clearance did not influence the amount 
of virus entering the lungs. Higher expression of TLRs, β2-microglobulin, BST2 and GBP1 in 
EX mice prior to infection and the pattern of increase in ISGs at 6 hours post infection suggests 
that exercise may “pre-activate” the immune system for invading pathogens, possibly with the 
help of danger signaling or response to exercise as a physical stressor. Another explanation could 
be that the increase in PRRs and anti-viral genes may be inhibiting the replication of virus during 
the first few cycles of replication, or infiltration of neutrophils and monocytes with exercise may 
be clearing some virus during the first day of infection.  
 In summary these findings demonstrate that regular, moderate treadmill exercise does 
benefit mice that are infected with influenza virus by reducing the viral load in the respiratory 
tract and altering the immune response to its advantage. Regular physical activity could prove to 
be very advantageous for older adults, more so than short bouts of exercise which may or may 
not have any effects on response to natural infections or vaccinations (135). 
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Figures for Chapter 3 
Table 1. Names, symbols and description of genes measured via PCR.  
Symbol Description 
Adar Adenosine deaminase, RNA-specific 
B2m Beta-2 microglobulin 
Bst2 Bone marrow stromal cell antigen 2 
Cxcl10 Chemokine (C-X-C motif) ligand 10 
Eif2ak2 or 
PKR 
Eukaryotic translation initiation factor 2-alpha 
kinase 2 
Gbp1 Guanylate binding protein 1 
Ifi204 Interferon activated gene 204 
Ifit1 or ISG56 
or Ifi56 
Interferon-induced protein with tetratricopeptide 
repeats 1 
Ifit3 or Ifi49 Interferon-induced protein with tetratricopeptide 
repeats 3 
Ifna2 Interferon alpha 2 
Ifna4 Interferon alpha 4 
Ifnb1 Interferon beta 1, fibroblast 
Irf7 Interferon regulatory factor 7 
Isg15 ISG15 ubiquitin-like modifier 
Mx1 Myxovirus (influenza virus) resistance 1 
Mx2 Myxovirus (influenza virus) resistance 2 
Oas1a 2'-5' oligoadenylate synthetase 1A 
Oas1b 2'-5' oligoadenylate synthetase 1B 
Oas2 2'-5' oligoadenylate synthetase 2 
Stat2 Signal transducer and activator of transcription 2 
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Figure 1. 
 
Figure 1: Effect of exercise on mRNA expression of ISGs. Whole lung homogenates were 
obtained from uninfected mice and were tested for mRNA expression by quantitative Real Time 
PCR. * indicates a significant effect of exercise (q value<0.05), + indicates trend (q value <0.1, p 
value <0.05). 
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Figure 2 
 
 
Figure 2: Effect of exercise on mRNA expression of TLR proteins. Whole lung homogenates 
were obtained from uninfected mice and were tested for mRNA expression by quantitative Real 
Time PCR. * indicates a significant effect of exercise (q value<0.05), + indicates trend (q value 
<0.1, p value <0.05). 
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Figure 3 
 
 
Figure 3: Viral load in BALF and lungs of young and old mice day 1 after infection with 
influenza virus. Viral load was detected by quantitative PCR for influenza NP protein. Statistical 
significance was determined by one-way ANOVA, * indicates a significant (p<0.05) effect of 
age. 
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Figure 4A 
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Figure 4B 
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Figure 4C 
 
Figure 4A – 4C: Effect of exercise on mRNA expression of type I IFN and ISGs in infected 
mouse lung homogenates. Whole lung homogenates were obtained from mice infected with 
influenza and tested for mRNA expression by quantitative Real Time PCR. The fold changes 
presented were calculated as the fold change of old exercise mice compared to old non exercise 
mice at the same time point post infected. This was calculated and comparisons are presented for 
(4A) 6 hours, (4B) 12 hours and (4C) 24 hours post infection. * indicates a significant effect of 
exercise (q value<0.05), + indicates trend (q value <0.1, p value <0.05). 
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Figure 5 
 
Figure 5: Effect of exercise on mRNA expression of TLRs in infected mouse lung homogenates. 
Whole lung homogenates were obtained from mice infected with influenza and tested for mRNA 
expression at 24 hours post infection by quantitative Real Time PCR. The fold changes presented 
were calculated as the fold change of old exercise mice compared to old non exercise mice at the 
same time point post infected. * indicates a significant effect of exercise (p value<0.05), + 
indicates trend (0.05<p <0.1). 
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Table 2 
Cytokine 
EX 
Infected 
NON EX 
Infected 
  (pg/ml) (pg/ml) 
p 
value 
G-CSF 382.183 447.957   
IL-1a 97.9888 114.014   
IL-1b 21.8875 29.7 + 
IL2 12.2675 16.28 + 
IL6 1288.31 2173.54 + 
IL10 33.1386 38.309   
KC 956.043 1447.06 + 
IP10 745.433 1112.88 + 
MCP1  316.508 410.586   
MIG 331.183 380.502   
MIP-1a 34.6171 39.552   
MIP1b 156.82 159.926   
MIP2 168.912 173.764   
RANTES 30.4817 34.338   
TNFa 29.9533 25.012   
VEGF 84.764 156.49   
 
Table 2. Cytokines and chemokines were measured using Bioplex assay. Concentration of 
protein levels in BALF are presented for exercise (EX) infected and non-exercise (NON EX) 
infected groups at day 1 post influenza infection. + denotes significant trend effect of exercise 
(0.05<p<0.1). 
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Figure 6 
 
Figure 6: Ciliary beat frequency (CBF) was calculated in the trachea of young mice, old mice 
and old exercise mice. The baseline CBF and CBF after stimulation with beta agonist are shown. 
* indicates a significant effect of exercise (p value<0.05), + indicates trend (0.05<p <0.1). 
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Figure 7A 
 
 
 
 
 
 
 
 
 
 
 
 
  
*
0
20000
40000
60000
80000
100000
120000
140000
160000
Live cells
N
u
m
b
e
r 
o
f 
ce
ll
s
Total Live cells in Lungs
Old Ex Infected
Old Infected
Old Ex NI
Old NI
115 
 
Figure 7B 
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Figure 7C 
 
 
 
 
 
 
 
 
 
 
 
 
  
*
*
*
*
*
*
0
2000
4000
6000
8000
10000
12000
14000
16000
Inflammatory 
Monocytes
Neutrophils DC pDC Constitutive 
monocytes
Alveolar 
Macrophages
N
u
m
b
e
r 
o
f 
ce
ll
s
Cell counts in Lungs
Old Ex 
Infected
Old Infected
Old Ex NI
Old NI
117 
 
Figure 7D 
 
 
Figure 7A – 7D: Cell populations were detected in BALF and lungs of mice using flow 
cytometry. Total numbers of live cells are shown in (7A) lungs and (7B) BALF of uninfected 
mice and infected mice at day 1 post influenza infection. (7C) shows the cell counts of 
inflammatory monocytes, neutrophils, DC, pDC, constitutive monocytes and alveolar 
macrophages in the lungs of mice and (7D) shows cell counts for inflammatory monocytes, DC, 
pDC and alveolar macrophages in BALF of mice. Statistical significance was determined by 
one-way ANOVA, * indicates a significant effect of age (p value<0.05), + indicates trend (0.05< 
p <0.1). 
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Figure 8A 
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Figure 8B 
 
Figure 8A – 8B: Cell populations were detected in BALF and lungs of mice using flow 
cytometry and cell frequencies were calculated as the percentage of total live cells for each 
population. (8A) shows the cell frequencies of inflammatory monocytes, neutrophils, DC, pDC, 
constitutive monocytes and alveolar macrophages in the lungs of mice and (8B) shows cell 
frequencies for inflammatory monocytes, DC, pDC and alveolar macrophages in BALF of mice. 
Statistical significance was determined by one-way ANOVA, * indicates a significant effect of 
age (p value<0.05), + indicates trend (0.05< p <0.1). 
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CHAPTER 4 
ACUTE EXERCISE INDUCES A STRESS RESPONSE IN LUNGS OF MICE 
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Abstract 
 Exercise is considered to be a type of physical stress, and the effects of exercise stress on 
tissues such as cardiac or skeletal muscle are well documented.  However, the effects of acute 
exercise stress on lung cellular response are not well understood.  In addition to potential cellular 
stress, exercise via increased ventilation may expose the respiratory tract to pathogens.  Although 
it is conceivable that pathways involved in cellular stress or pathogen recognition/response may 
be upregulated in the lung in response to acute exercise, the lung cellular defense pathway 
response to acute exercise remains largely unknown.  The purpose of this experiment was to 
determine if exercise (acute and chronic) acts as a moderate stressor that could alter cellular 
defense pathways and immune cell populations in the lung. Mice were exercised for either 45, 
90, or 180 minutes to compare effects of moderate and prolonged exercise.  A separate group of 
mice exercised regularly (5 d/week, 45 min/day) for 8 weeks to determine whether regular 
exercise training results in adaptations in host cellular stress/defense pathways.  Quantitative 
PCR arrays were used to determine stress and toxicity pathways in whole lungs, and innate 
immune cell populations were identified in the bronchoalveolar lavage fluid and the lungs.  
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Acute exercise resulted in increased expression of heat shock proteins as well as several genes 
associated with regulation of inflammation. The expression of genes related to apoptosis was not 
generally altered with acute exercise, although Cdkn1a which may limit proliferation was 
increased after acute exercise.  Chronic exercise training for 8 weeks resulted in a down-
regulation of heat shock proteins, and did not change expression of genes associated with 
apoptosis or inflammation. Exercise training may cause a shift of CD45 positive immune cells 
from the BAL into the lungs as the CD45+ population decreased in the BAL, but increased in the 
lung.  Also, exercise training was associated with a decreased number of inflammatory 
monocytes in the BAL, but an increased number of alveolar macrophages in the lung.  Taken 
together, these changes may suggest that exercise training may promote an anti-inflammatory 
environment in the lung.  It is possible that exercise training may cause the lung tissue to adapt to 
the stress and thus lead to a downregulation of heat shock proteins and control any inflammation 
that may be caused due to exercise. A shift in immune cells from BALF to lungs may explain our 
previous findings of reduced viral titer and decreased inflammation with influenza infection in 
exercise trained mice.  
Introduction 
 Several forms of physical stressors may alter the immune system in several ways. 
Exercise may be considered a physical stressor, along with traumatic injury, hypoxia, thermal 
injury and surgery (92). A single session of exercise (or acute exercise) alters the immune system 
in several different ways. Acute exercise leads to a mobilization of immune cells, as neutrophils,  
lymphocyte subsets – particularly CD8+ cells,  and NK cells are increased in circulation during 
exercise and are either decreased or return to baseline levels shortly after exercise ceases (196). It 
has been hypothesized that lymphocytes are recruited to circulation from tissue pools such as the 
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spleen, lymph nodes, the gastrointestinal tract, and possibly the lung, yet are redistributed back 
into tissues either shortly after exercise or during prolonged and/or high intensity exercise. 
However, the organs or tissues that these cells are redistributed to  is not completely clear (170). 
Lymphocyte proliferation in response to T cell mitogens phytohemagglutinin and concanavalin 
A decreases during and immediately after exercise (159), although this may reflect the decrease 
in percentage or proportion of lymphocytes in tissue after recruitment to the blood. Current 
literature suggests that exercise induces an increase in the proinflammatory cytokines TNF-α, IL-
1β and IL-6 as well as cytokine inhibitors IL-1ra and TNF receptors (TNF-R) and the anti-
inflammatory cytokine IL-10 in the serum, although these changes in cytokines are dependent 
upon duration and intensity of exercise (166). Also, the concentration of salivary IgA was 
reported to be reduced with prolonged physical activity in a number of studies.  In general, the 
effects of exercise on immune cell responses vary with the intensity, duration and type of 
exercise. For example while moderate exercise improves neutrophil functions of chemotaxis, 
phagocytosis, and oxidative burst activity, some of these functions such as phagocytosis are not 
affected by extreme physical activity (165, 205).  
 Acute exercise leads to activation of the hypothalamic-pituitary-adrenal responses that 
impact the immune system (171). It increases the concentrations of a number of stress hormones 
in the blood, including epinephrine, norepinephrine, growth hormone, β-endorphins, 
testosterone, estrogen, and cortisol. The catecholamines epinephrine and norepinephrine are 
thought to regulate cell trafficking and recruitment into circulation during exercise for NK and 
CD8+ cells. The plasma concentrations of cortisol and β-endorphins typically increase in 
response to prolonged and/or strenuous exercise and therefore may not play a role in immune 
modulation resulting from moderate duration moderate intensity exercise.   
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 One session of acute eccentric exercise may increase the antibody response to 
vaccination, although this has not been a consistent finding and the mechanisms are not 
identified (47). The type, amount and duration of exercise that could be used as an “adjuvant” for 
vaccinations are still unclear.  Previous experiments in our lab have suggested that chronic 
exercise training as well as a single session of acute exercise decrease lung viral load when 
exposure to virus occurred after the exercise session.  These previous findings raise the 
possibility that exercise may act as a moderate stressor, potentially upregulating the ability to 
respond to other stressors such as infection.  However, the effects of acute exercise or exercise 
training on lung cellular stress pathways, and/or innate host defense pathways remains unknown.  
Therefore, the purpose of this experiment was to determine whether exercise (acute and chronic) 
induces a stress response and expression of “danger signals” in the lungs of mice.  In addition, 
we examined whether exercise might alter the number and type of immune cell subpopulations 
found in either the bronchoalveolar lavage fluid (BALF) or the lung. The stress response was 
evaluated by detection of relevant genes associated with apoptosis, inflammation and heat shock 
proteins (HSP) using quantitative Real Time PCR on whole lung homogenates obtained from 
mice.  
Materials and Methods  
Animals and exercise procedure 
 Adult BALB/c mice (4-6 months of age) were obtained from Jackson laboratories and 
randomly assigned to the following groups: No exercise (0-ex), single session 45 minutes of 
exercise (45-ex), single session 90 minutes of exercise (90-ex), single session 180 minutes of 
exercise (180-ex), and chronic exercise training (EX). The mice in the EX group were exercise-
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trained on a treadmill for 8-10 weeks. Exercise duration was gradually increased during weeks 1 
to 4; from weeks 5 to 8, mice ran 40–45 min/day; then 45 min/day for the remainder of the 
training period. Speed progressed from 8 m/min during week 1 to 18 m/min by week 8. The 
NON-EX group did not exercise. The exercise-trained mice were euthanized 24 hours after their 
last bout of exercise. The single session exercise groups ran on the treadmill for their group’s 
respective time (45 minutes, 90 minutes and 180 minutes) and were euthanized within 15 
minutes post exercise. All animal procedures were approved by the Institutional Animal Care 
and Use Committee (IACUC). 
Tissue collection  
 Mice were euthanized by cervical dislocation and lung lobes were collected for RNA 
isolation and flow cytometry. BALF was collected by inserting a catheter attached to a syringe 
through an incision in the trachea, and airways were flushed three times with 1 mL of PBS. The 
BALF was centrifuged, cells were collected for analysis by flow cytometry, and the supernatant 
was stored at -80°C until subsequent analysis. RNA was isolated using TRIzol Reagent 
(Invitrogen, Carlsbad, California).  Lung RNA was further purified using the RNeasy Micro Kit 
(QIAGEN, Valencia, California) then frozen at -80°C until further testing was carried out by 
PCR. 
qPCR and PCR Microarray 
 Five hundred ng of purified lung mRNA was analyzed for stress and toxicity pathways 
gene expression using the 96-well Stress and Toxicity Pathway Finder RT² Profiler™ PCR Array 
(SABiosciences, Frederick, Maryland) and protocol provided with the array (n= 4 to 5). Samples 
were analyzed using the BioRad MyiQ PCR system and Optical System Software Version 1.0. 
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GAPDH, beta actin, Hypoxanthine-Guanine Phosphoribosyltransferase and beta galacturonidase 
were used as the reference housekeeper genes. 
Identification of Lung Cell Populations by Flow Cytometry 
 Cell populations were determined in BALF from 0-ex, 45-ex, 90-ex, 180 ex groups and 
in BALF and lungs in the EX group and 0-ex controls (n= 8 to 10). Live cells were gated by 
comparing forward scatter with side scatter and deselecting the cells with low forward and side 
scatter. Lungs were homogenized in collagenase containing media and single-cell suspensions of 
lungs were obtained using a 40µm cell strainer. Alveolar macrophages (Highly autofluorescent, 
CD11c high, CD11b low, Gr1 negative), constitutive monocytes (CD11b positive, Gr1 negative), 
pDCs (CD11b low, CD11c intermediate, mPDCA positive, low autofluorescence), neutrophils 
(CD11c negative, CD11b positive, Gr1 high, high side scatter), and inflammatory monocytes 
(CD11b positive, Gr1 high, CD11c negative, low side scatter) were identified in cells obtained 
from whole lung homogenate and BAL. Expression of CD45 was used to identify cells as 
leukocytes or non-leukocytes.  Flow cytometry was performed using a FACSCanto flow 
cytometer. FlowJo 7.6 software was used for gating and analysis. 
Statistical Analysis 
 All statistical analysis was performed using SABiosciences PCR Data Analysis software 
and SPSS Statistics 17.0. A one-way ANOVA was used to compare gene expression and 
immune cell populations for differences in response to each exercise treatment.  In cases in 
which a significant main effect of treatment was found, Fisher’s LSD post-hoc comparisons were 
made.  Statistical trends were denoted by p <0.1 and significance levels for all tests were set at p 
<0.05.  
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Results 
Heat Shock Proteins were up-regulated with acute exercise and down-regulated with chronic 
exercise  
 Acute exercise led to up-regulation of heat shock protein subunits Dnaja1, Hspa1b, 
Hspa5, Hspa8, Hspb1, Hspd1, Hspe1, Hsp90ab1 and Serpine1 (Table 1). Several genes including 
DNAJA1 and HSPA1B peaked 45 minutes into the exercise session.  In general, the results 
indicated that there was a progressive increase in expression as exercise duration increased 
(Hspa5, Hspa8, Hspb1, Hspd1, Hspe1, Hsp90ab1).  In contrast, 8 weeks of exercise training 
resulted in a downregulation of multiple heat shock proteins (measured 24 hours after the last 
exercise session) (Table 1).  
Apoptosis was not induced by acute or chronic exercise  
 Pro-apoptotic genes coding for Caspase 1 (CASP1), Caspase 8 (CASP8), Fas Ligand 
(FASL), TNF receptor (TNFRSF1A), Bcl-2-associated X protein (BAX), TNF-related apoptosis-
inducing ligand (TRAIL) and TNFR1-Associated Death Domain Protein (TRADD) were either 
unchanged or reduced with acute exercise (Table 2). However, the anti-apoptotic gene BCL2L1 
was up-regulated by greater than 2 fold after 90 minutes and sustained the increase till 180 
minutes of exercise. The CDKN1A gene encodes a potent cyclin-dependent kinase inhibitor 
which functions as a regulator of cell cycle progression at G1. This gene is strongly up-regulated 
by acute exercise, up to a 5.2 fold increase by 90 minutes. With respect to eight weeks of 
exercise training, apoptosis genes were generally unchanged, except for a trend toward increased 
expression of the anti-apototic gene BCL2L1.  
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“Controlled” inflammation may be induced after acute exercise, but was not induced with 
chronic exercise  
 Genes for cytokines and chemokines associated with inflammation were detected by PCR 
in mouse lungs (Table 3). The most consistent changes observed across acute exercise treatments 
were an increase in the expression of NFκB inhibitor NFKBIA, IL-6, and MIP-1a.  With 45 
minutes of exercise, a trend towards a decrease in IL-1β  and IL-18 was found (genes associated 
with inflammasome activation).  With prolonged exercise (180 minutes) MIP1α, MIP1β, IL-1α, 
and IL-6 expression increased, although the NFκB inhibitor NFKBIA was also significantly 
increased at this time.   Following eight weeks of exercise training, none of the inflammatory 
genes were upregulated, and CSF2 showed a significant decrease in expression.  
Expression of miscellaneous genes induced by exercise 
 As shown in table 4, expression of EGR1 (transcriptional regulator Early Growth 
Response 1), MT2 (Metallothionein) and SERPINE1 (coding for Plasminogen activator 
inhibitor-1) mRNA were increased after acute and chronic exercise. NOS2 (Nitric Oxide 
synthase, inducible) and PCNA (Proliferating Cell Nuclear Antigen) were not induced by either 
acute or chronic exercise. NOS2 was down-regulated at 180 minutes of exercise. 
Antioxidants were not up-regulated due to exercise  
 There were no observed changes in superoxide dismutase coding SOD1 and SOD2 genes, 
or glutathione peroxidases GPX1 and GPX2 with either acute or chronic exercise (Table 5). 
 Acute exercise alters cell numbers in BALF of mice. 
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 Cell populations were detected using flow cytometry on BALF obtained from the mice 
(Figures 1A – 1C).  The total number of live cells decreased after 45 minutes of exercise relative 
to no-exercise treatment.  However, 180 minutes of exercise resulted in a greater number of cells 
in the BALF.  With respect to specific cell populations, the number and percentage of 
inflammatory monocytes tended to decrease with all durations of exercise, and constitutive 
monocyte percentage also tended to decline at all exercise time points.  The only cell population 
that increased after 180 minutes of exercise was the alveolar macrophage population.  
Chronic exercise increased immune cell numbers in lungs, but not in BALF 
 Cell populations were detected in lungs and BALF of mice that were trained for chronic 
exercise. Regular physical activity increased the live cell population in lungs of exercising mice 
which were mostly CD45 positive, which is a marker used to detect most immune cells (Figure 
3A). Cell numbers were higher for inflammatory monocytes, neutrophils and dendritic cells in 
exercise mouse lungs. Alveolar macrophages were increased in the non-exercise control mouse 
lungs (Figure 3B). Cell numbers in BALF were higher in the non-exercise control group, and 
these were explained by an increase in CD45 negative cells (Figure 4A). CD45 positive (immune 
cells) were not different in BALF of exercise and control groups. The individual cell populations 
detected were also similar in both groups (Figure 4B).   
Discussion 
 We discovered that in our model of acute exercise, heat shock proteins were expressed 
immediately after a single session of exercise, and increased in proportion to duration of exercise 
(45 minutes, 90 minutes and 180 minutes of exercise). Pro-apoptotic genes were not expressed, 
with some genes such as TRAIL being down-regulated after 90 minutes of exercise. Consistent 
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with the idea of reduced apoptosis, anti-apoptotic gene BCL2L1 was up-regulated. Cyclin-
dependent kinase inhibitor 1a (CDKN1A or p21), which is induced in response to DNA damage 
to halt cellular proliferation (57, 81) was also highly expressed with exercise, suggesting that 
exercise may signal the body to reduce cell division and channel the energy to burning fuel for 
exercise. Inflammation, which is another possible consequence of stress, was also tested by 
detection of cytokine mRNA. While a few such as CSF2 (GMCSF), IL18 and lymphotoxin α 
were not induced with exercise, cytokine mRNA for MIP1α and IL-6 were up-regulated after 45 
minutes of exercise and MIP1β and IL1a were up-regulated after 180 minutes of exercise. 
However, induction of NFκB inhibitor (NFκBIA) indicates that anti-inflammatory factors were 
also being up-regulated at the same time to control excessive inflammation (as is sometimes seen 
when inflammation is induced). Others have also suggested that the IL-6 response to exercise 
may serve an anti-inflammatory role.  In summary, a stress response was induced in the lung 
tissue of exercising mice as shown by heat shock protein expression. This stress did not induce 
apoptosis or extensive inflammation, but may arrest cellular proliferation of lung cells.  
 When the effects of chronic exercise were tested 24 hours after the last exercise session, a 
stress response in the lungs was not observed.  Instead, there was a down-regulation of HSP 
mRNA, which may be an adaptation to regular exercise training.  Also,  no significant increases 
in apoptosis-inducing mRNA or pro-inflammatory cytokine mRNA were found, which is 
consistent with previous data from our laboratory showing that exercise trained mice had lower 
levels of IL-1α  and IL-1β  cytokine concentration in BALF.  
 The antioxidant enzymes that were detected by PCR in this study, superoxide dismutase 
and glutathione peroxidase were similar in exercise and control groups, indicating that these 
were not induced in response to exercise. Results showing oxidative stress and activation of 
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antioxidants due to exercise have not been consistent and may require exhaustive exercise (98). 
While this may be true in muscle tissue, whether it occurs in healthy lung tissue is unknown.  
 After acute exercise, we also saw some changes in mRNA expression of other genes such 
as EGR1, MT2 and SERPINE1. EGR1 (Early Growth Response) encodes for a nuclear protein 
that is a transcriptional regulator, responsible for activating genes required for differentiation and 
mitogenesis. Studies suggest this is a cancer suppressor gene (96, 153). This is interesting 
because exercise has been associated with decreased risk of cancer (70) and effective in 
managing the side effects of cancer treatment (65). The expression of EGR1 could be a 
mechanism for these observed effects of exercise with respect to cancer. MT2 codes for 
Metallothioneins, which have the ability to bind various heavy metals due to a high content of 
cysteine residues. These proteins are transcriptionally regulated by both heavy metals and 
glucocorticoids. It is possible that glucocorticoids (such as cortisol) (118) induced by exercise 
stimulated the up-regulation of MT2 and it could function in removing any particles that may 
have been inhaled during the exercise session. SERPINE1 encodes a member of the serine 
proteinase inhibitor (serpin) superfamily, which is an inhibitor of tissue plasminogen activator 
(tPA) and urokinase (uPA), and hence is an inhibitor of fibrinolysis. Why this gene would be 
induced in response to exercise and how it would affect the lungs is unknown and could be a 
subject of future studies.  
 The source of the stress induced by exercise was not identified in these experiments. 
However, we observed that exercise does not induce apoptosis or extensive inflammation, and 
therefore, it is not likely that apoptotic or inflammatory pathways contribute to the HSP 
response. Other potential sources of stress could be physical stress on the lung tissue or factors 
such as inhaled particles during the treadmill exercise. 
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 The data on cell populations in the BALF showed a pattern of decrease at 45 minutes of 
exercise that gradually increased to a level equal to or higher than the control group after 180 
minutes of exercise. Whether this indicates a mobilization into the blood or a shift into the lungs 
is not clear as we do not have data on lung cell populations. We did observe that alveolar 
macrophage numbers were higher at 180 minutes of exercise as compared to the controls. 
Alveolar macrophages can be anti-inflammatory by releasing prostaglandins, IL-4, IL-10 and 
transforming growth factor-β (TGF-β) (109, 251). Although these cytokines were not tested for 
by PCR, alveolar macrophages may be acting to control the inflammation that was indicated by 
the cytokine mRNA data. Exercise training in mice increased CD45 positive immune cell 
numbers in the lungs, but not in BALF. Immune cells could be moving from the BAL into the 
lungs, increasing the inflammatory monocytes, neutrophils and dendritic cell numbers in lungs of 
trained mice.  
 In conclusion, this study discovered that a single session of exercise induces a heat shock 
protein response in the lung tissue of mice. Other studies have shown an HSP response in other 
tissues such as skeletal muscle, heart and liver during the exercise session (189). Also ours is the 
first study to show that HSP response is actually down-regulated in the lungs 24 hours after 
exercise training, indicating an adaptation of the lung tissue over time, possibly to prevent over 
stimulation of the stress response. We also discovered that exercise does not induce an apoptotic 
or antioxidant response and may induce some inflammation in the lung during and immediately 
after a single session of exercise. An increase in alveolar macrophages may be a part of the 
inflammatory response and act to control excessive inflammation in the lungs. Higher CD45 
positive immune cell numbers in the lungs after exercise training could help explain the 
resistance to certain diseases (such as cancer) that exercise is associated with.  
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Figures for Chapter 4 
Table 1. 
  45 mins Ex 90 mins Ex 180 mins Ex Chronic Ex 
Gene 
Name 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Cryab 0.991 0.959 0.810 0.022 0.778 0.012 0.665 0.000 
Dnaja1 2.100 0.004 2.019 0.054 1.585 0.104 0.673 0.060 
Hspa1b 4.786 0.010 3.168 0.119 1.323 0.733 0.470 0.140 
Hspa1l 1.326 0.075 1.042 0.706 0.980 0.825 0.924 0.953 
Hspa4 1.435 0.000 1.188 0.185 1.421 0.005 0.733 0.005 
Hspa5 1.469 0.002 1.515 0.038 1.630 0.008 0.586 0.001 
Hspa8 1.718 0.018 1.747 0.038 2.015 0.006 0.474 0.004 
Hspb1 2.399 0.002 2.332 0.076 5.707 0.006 0.780 0.238 
Hspd1 1.405 0.064 1.549 0.092 2.203 0.009 0.602 0.016 
Hspe1 1.616 0.005 1.550 0.097 2.621 0.025 0.832 0.107 
Hsp90ab1 1.678 0.006 1.471 0.153 2.629 0.001 0.745 0.127 
 
Table 1: Fold change in gene expression of Heat Shock Protein subunits of four exercise groups 
– 45 minutes, 90 minutes, 180 minutes and chronic exercise each compared to no-exercise 
controls. Whole lung homogenates were tested for mRNA expression by quantitative Real Time 
PCR. Fold change numbers greater than 1.5 fold and less than 0.67 have been highlighted. Fold 
changes in bold font indicate significance (p<0.05) and fold change numbers in italics indicate 
(0.05< p <0.1). 
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Table 2. 
  45 mins Ex 90 mins Ex 180 mins Ex Chronic Ex 
Gene Name Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Casp1 0.809 0.011 0.765 
0.02
8 0.857 
0.28
9 1.359 
0.05
4 
Casp8 0.892 0.261 0.789 
0.01
7 0.853 
0.15
8 0.965 
0.90
2 
Fasl 1.304 0.265 0.653 
0.42
1 0.819 
0.40
9 1.191 
0.45
5 
Tnfrsf1a 0.908 0.091 0.925 
0.41
6 0.977 
0.84
8 0.920 
0.08
2 
Bax 1.066 0.443 0.942 
0.64
7 0.952 
0.49
5 0.893 
0.32
4 
Bcl2l1 1.367 0.025 2.174 
0.00
0 2.339 
0.00
0 1.347 
0.07
6 
Cdkn1a 3.703 0.000 5.203 
0.00
0 4.900 
0.00
0 1.022 
0.84
9 
Tnfsf10/TRAI
L 0.709 
0.04
5 0.478 
0.00
4 0.558 
0.00
5 0.941 
0.45
4 
Tradd 0.781 0.256 0.836 
0.09
4 0.842 
0.19
6 0.932 
0.62
4 
 
Table 2: Fold change in gene expression of apoptosis associated genes of four exercise groups – 
45 minutes, 90 minutes, 180 minutes and chronic exercise each compared to no-exercise 
controls. Whole lung homogenates were tested for mRNA expression by quantitative Real Time 
PCR. Fold change numbers greater than 1.5 fold and less than 0.67 have been considered. Fold 
changes in bold font indicate significance (p<0.05) and fold change numbers in italics indicate 
(0.05< p <0.1). 
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Table 3. 
  45 mins Ex 90 mins Ex 180 mins Ex Chronic Ex 
Gene 
Name 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Ccl3/MIP-
1a 1.621 0.074 2.706 0.066 3.416 0.008 1.353 0.114 
Ccl4/MIP-
1b 1.116 0.459 1.033 0.583 1.516 0.183 0.945 0.560 
Csf2 0.966 0.882 1.025 0.764 0.913 0.197 0.551 0.015 
Cxcl10 0.765 0.621 0.622 0.167 0.859 0.544 0.779 0.374 
Il18 0.753 0.074 0.970 0.698 1.194 0.102 0.981 0.961 
Il1a 1.135 0.278 1.117 0.303 1.543 0.017 1.285 0.000 
Il1b 0.583 0.108 0.690 0.755 0.693 0.280 1.213 0.760 
Il6 1.718 0.232 1.703 0.278 2.486 0.114 0.797 0.420 
Lta 0.656 0.357 0.627 0.186 1.106 0.913 1.334 0.415 
Mif 0.964 0.654 0.977 0.724 0.950 0.699 1.015 0.862 
Nfkb1 1.104 0.017 1.030 0.551 0.999 0.918 0.997 0.967 
Nfkbia 2.148 0.000 2.240 0.000 2.288 0.000 1.208 0.026 
 
Table 3: Fold change in gene expression of genes associated with inflammation of four exercise 
groups – 45 minutes, 90 minutes, 180 minutes and chronic exercise each compared to no-
exercise controls. Whole lung homogenates were tested for mRNA expression by quantitative 
Real Time PCR. Fold change numbers greater than 1.5 fold and less than 0.67 have been 
considered. Fold changes in bold font indicate significance (p<0.05) and fold change numbers in 
italics indicate (0.05< p <0.1). 
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Table 4. 
  45 mins Ex 90 mins Ex 180 mins Ex Chronic Ex 
Gene 
Name 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Egr1 1.632 0.191 2.363 0.008 4.599 0.001 1.611 0.167 
Mt2 1.659 0.069 2.344 0.005 6.221 0.019 1.408 0.143 
Nos2 1.053 0.664 0.864 0.379 0.577 0.052 1.006 0.965 
Pcna 0.916 0.423 0.949 0.370 1.034 0.683 0.775 0.055 
Serpine1 2.921 0.001 2.819 0.001 2.430 0.003 1.548 0.091 
 
Table 4: Fold change in gene expression of four exercise groups – 45 minutes, 90 minutes, 180 
minutes and chronic exercise each compared to no-exercise controls. Whole lung homogenates 
were tested for mRNA expression by quantitative Real Time PCR. Fold change numbers greater 
than 1.5 fold and less than 0.67 have been considered. Fold changes in bold font indicate 
significance (p<0.05) and fold change numbers in italics indicate (0.05< p <0.1). 
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Table 5. 
  45 mins Ex 90 mins Ex 180 mins Ex Chronic Ex 
Gene 
Name 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Fold 
change 
p-
value 
Sod1 1.007 0.891 1.010 0.852 1.131 0.341 0.868 0.262 
Sod2 1.188 0.162 1.003 0.682 0.941 0.506 1.051 0.611 
Gpx1 0.966 0.839 1.120 0.140 0.967 0.719 0.785 0.031 
Gpx2 0.998 0.915 0.736 0.050 1.197 0.191 1.082 0.507 
 
Table 5: Fold change in gene expression of antioxidants in four exercise groups – 45 minutes, 90 
minutes, 180 minutes and chronic exercise each compared to no-exercise controls. Whole lung 
homogenates were tested for mRNA expression by quantitative Real Time PCR. Fold change 
numbers greater than 1.5 fold and less than 0.67 have been considered. Fold changes in bold font 
indicate significance (p<0.05) and fold change numbers in italics indicate (0.05< p <0.1). 
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Figure 1A. 
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Figure 1B. 
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Figure 1C. 
 
 
Figure 1A – 1C: Using flow cytometry, cell populations were detected in BALF of mice that 
underwent a single session of acute exercise. Total numbers of live cells in BALF are shown in 
(1A). (1B) shows the cell counts of constitutive and inflammatory monocytes in BALF. (1C) 
shows the cell counts for DC and alveolar macrophages in the BALF. Statistical significance was 
determined by one-way ANOVA, * indicates a significant effect of age (p value<0.05), + 
indicates trend (0.05< p <0.1). 
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Figure 2A. 
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Figure 2B. 
 
 
Figure 2A – 2B: Cell populations were detected in BALF and lungs of mice using flow 
cytometry and cell frequencies were calculated as the percentage of total live cells for each 
population. (2A) shows the cell frequencies of alveolar macrophages and DC, (2B) shows the 
frequencies for constitutive and inflammatory monocytes in BALF. Statistical significance was 
determined by one-way ANOVA, * indicates a significant effect of age (p value<0.05), + 
indicates trend (0.05< p <0.1). 
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Figure 3B. 
 
Figure 3A – 3B: Cell populations were detected in lungs of mice that exercised regularly for 8 
weeks. (3A) Total numbers of live cells are shown in lungs and (3B) shows the cell counts of 
inflammatory monocytes, neutrophils, DC and alveolar macrophages in the lungs of mice. 
Statistical significance was determined by one-way ANOVA, * indicates a significant effect of 
age (p value<0.05), + indicates trend (0.05< p <0.1). 
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Figure 4B. 
 
Figure 4A – 4B: Cell populations were detected in BALF of mice that exercised regularly for 8 
weeks. (4A) Total numbers of live cells are shown in BALF and (4B) shows the cell counts of 
inflammatory monocytes, constitutive monocytes and DC in the BALF of mice. Statistical 
significance was determined by one-way ANOVA, * indicates a significant effect of age (p 
value<0.05), + indicates trend (0.05< p <0.1). 
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CHAPTER 5 
SUMMARY AND CONCLUSIONS FOR THE DISSERTATION 
It has been well established that aging modulates immune function in animal models, including 
mice. The mechanisms of this immune modulation are still being investigated, although most 
studies indicate an increased risk and susceptibility to infection, impairment and/or delay in 
response to certain pathogens (1). One consequence of this phenomenon which is also called 
immunosenescence is the reduced response to vaccinations in the elderly, especially to influenza 
vaccinations (73, 78). Influenza A virus causes infection in the respiratory tract of humans (and 
other animals such as mice, poultry, horses and swine). Apart from weakened vaccine responses, 
immunosenescence causes increased risk, susceptibility and severity of infections, increasing 
morbidity and mortality in aged hosts (38, 73, 222). Exercise is an intervention that has been 
found beneficial for general well-being and also in many illnesses and infections (201). 
In this dissertation, we intended to examine the effects of age on innate immunity in 
mouse lungs, relevant to influenza infections. More specifically, the pathways specific for 
pathogen recognition, anti-viral type I IFN induction and inflammation were detected along with 
innate cell populations such as alveolar macrophages, neutrophils and monocytes in the lungs 
and bronchoalveolar lavage fluid (BALF) in BALB/c mice. We then continued to examine the 
same pathways and cell populations in lungs, in response to exercise training in aged mice. This 
enabled us to study the effects of exercise on the anti-viral immunity to influenza infections in 
aged lungs. Our final study was conducted in order to determine the stress response in the lungs 
caused by regular physical activity, if any, and how it differed from the stress response elicited 
by a single session of exercise.  
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In chapter 2, our studies demonstrated the alterations in the innate immune system with 
age in the mouse respiratory tract. While systemic inflammation has been reported in other 
healthy aged animal systems (8, 144), we discovered that inflammaging occurred in the lungs of 
old mice (prior to infection or illness). Age may alter the immune status prior to infection due to 
a decrease in few anti-viral genes such as ADAR1, β2m, PTX3 and PKR. Even though the TLR 
expression may not be reduced, decreased TLR adaptor proteins may reduce signaling and these 
could explain the decreased functions of TLR receptors reported by other groups.  
 Mice were then infected with influenza virus and the same pathways were studied early 
in the course of the infection. We observed that viral load is lower in lungs of old mice as 
compared to young mice, along with reduced activation of PRRs, inflammatory cytokines (IL1b, 
TNF, IL6 and CCL2) and activation markers (such as CD80/86, Ly86) and a delayed activation 
of type I IFN response starting from 6 hours PI till 24 hours PI (as compared to young mice 
infected with the same dose of virus). The data obtained from flow cytometry showed reduced 
cell numbers in old mice in both lungs and BALF. These data, taken together, suggested that 
viral uptake into cells may be impaired with age and the delayed immune activation early in 
infection may lead to inefficient viral clearance in old mice later in the course of infection. Even 
though healthy aged mice had higher levels of inflammatory cytokine mRNA prior to infection, 
the fold change of mRNA for activation and inflammatory markers at day 1 post infection were 
lower in old mice. This study provided further evidence for immune impairments with aging 
with respect to the pathways of antiviral response that were studied.  
In chapter 3 we demonstrated the effects of exercise in aged mice on the same pathways 
studied in chapter 2. Healthy (uninfected) mice that regularly exercised on a treadmill for 5 days 
per week, for 8-10 weeks expressed higher levels of TLRs and a few ISGs such as β2-
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microglobulin, BST2 and GBP1 in lungs and lower IFNα2. Cell numbers were also increased in 
lungs and BALF of exercise trained mice. This could represent more initial immune activation 
(or “pre-activation”) in physically active mouse lungs.  
After the mice were infected with influenza virus, viral load was measured and the same 
innate immune pathways were compared in exercise and non-exercise mice at day 1 PI. Regular 
exercise reduced the viral load in respiratory tract of mice that were regularly exercised. 
Although TLRs and ISG response was similar in both groups of mice at day 1 PI, the pattern of 
gene expression suggested a faster activation of IFN inducible genes. Cytokine and chemokine 
concentrations were also reduced with exercise in the infected mice. Cell populations were also 
very similar in the lungs at day 1 PI, with less inflammatory and more constitutive monocytes 
and pDCs in the lungs of exercised infected group of mice.  
To determine whether the entry of viral particles was impaired due to exercise, the ciliary 
beat frequency (CBF) was calculated in the trachea. There was no difference between CBF of 
exercise and non-exercise mice, showing that the mucociliary escalator is not altered by exercise 
training and would not affect the amount of virus particles entering the respiratory tract.  
This study proved that regular, moderate treadmill exercise did reduce viral load in the 
lungs at day 1 post infection. We hypothesized that this could be due to a “pre-activation” of the 
immune system in response to exercise as a stressor and/or activation of danger signals in the 
lungs. Another explanation could be that the shift in cell populations in the physically active 
mice may enable clearance of virus very early in the course of infection.  
To investigate our first hypothesis that regular chronic exercise elicits a stress response in 
the lungs of mice, we decided to determine stress response in lungs of mice that exercised on a 
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treadmill for 8 weeks and in lungs of mice that underwent a single session of moderate acute 
exercise of increasing duration for comparison. These results were presented in chapter 4. Genes 
involved in the heat shock protein response, apoptosis, inflammation, antioxidants which are 
induced by stress were studied in this chapter. We discovered that acute exercise led to an 
increase in heat shock protein response that is proportional to the duration of exercise (45 
minutes, 90 minutes and 180 minutes). Inflammation with IL1a, IL6 and MIP1α was induced in 
the lungs, but inhibitor of NFκB was also induced to control inflammation. Although apoptosis 
was not induced with acute exercise, cell proliferation might be arrested, possibly in order to 
shunt energy away from these cell processes. In summary, a stress response was induced in the 
lung tissue of exercising mice as shown by heat shock protein expression. This stress did not 
induce apoptosis or extensive inflammation, but may arrest cellular proliferation of lung cells. 
However, when the same genes were detected 24 hours after the last exercise session in 
trained mice, we did not notice a stress response in the lungs. In fact heat shock proteins were 
down-regulated, indicating that exercise training may cause an adaptation of the lungs to prevent 
over-stimulation of the stress response.  
When cell populations were detected in the BALF and lungs using flow cytometry, our 
data suggested that acute exercise caused a shift of the cells from the BALF during exercise that 
gradually returned to the BALF as the duration of the exercise increased to 180 minutes. Chronic 
exercise increased the number of immune cells in the lungs, which is consistent with data 
presented in chapter 3 in aged mouse lungs.  We concluded that immune cells could be moving 
from the BAL into the lungs, increasing the inflammatory monocytes, neutrophils and dendritic 
cell numbers in lungs of trained mice. This alteration in cell populations due to chronic exercise 
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could lead to more viral clearance when virus is introduced into the respiratory tract, leading to 
lower viral load, immune activation and inflammation in the lungs of exercising mice.  
In conclusion, this dissertation demonstrated immunosenescence in aging and uncovered 
some of the mechanisms of innate immunity that are affected by advanced age. We established 
that regular moderate level of exercise is beneficial to aged hosts in case of a respiratory 
influenza infection. Our final study identified some pathways and alterations in cellular 
composition in the lungs that may be responsible for this observed phenomenon.  
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APPENDIX 
SUPPLEMENTARY DATA AND FIGURES 
 
Figure 1A 
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Figure 1B. 
 
 
Figure 1A and 1B. Twenty-four hours after the last exercise session, mice were infected via an 
intranasal route with influenza virus strain A/PR/8/34 (H1N1) at a dose of 163.84 HA units per 
mouse (stock virus – HAU= 1024/0.05mL or 10^9.5/mLEID50 diluted 1:6.25 in sterile saline). 
Viral load was measured in the lungs using qRT-PCR. Figure 1A: Mice were infected with virus 
that was inactivated using BEI. No significant difference was seen in lung viral load of exercise 
and non-exercise mice. Figure 1B: Mice were infected with active/live virus. 
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Figure 2A 
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Figure 2B 
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Figure 2C 
 
6 hours PI 
  
 
Old 
Exercise 
Old Non 
Ex 
Young Non 
Ex 
Eotaxin 43.21 43.59 22.53 
GCSF 144.67 769.23 112.17 
GMCSF 47.50 32.06 18.91 
IFNg 25.54 2899.54 159.28 
IL1a 63.63 25.10 26.94 
IL1b 22.83 18.36 31.17 
IL2 32.36 5.10 11.35 
IL5 13.45 15.93 4.20 
IL6 694.16 351.11 460.70 
IL9 212.31 156.10 251.65 
IL10 10.85 107.67 3.29 
IL12p40 26.89 3.43 11.52 
IL12p70 25.12 10.49 8.88 
IL13 21.80 43.30 17.43 
IL15 19.87 11.02 4.55 
IP10 3693.77 4510.01 2890.14 
KC 453.09 336.50 325.67 
LIF 2.44 55.31 27.22 
LIX 601.33 147.69 188.66 
MCP1 306.05 343.64 92.49 
MCSF 17.60 12.46 7.36 
MIG 2321.29 16888.70 6668.52 
MIP1a 36.10 82.70 113.59 
MIP1b 65.62 139.39 152.51 
MIP2 100.40 91.49 132.11 
RANTES 21.08 27.17 26.09 
TNFa 7.64 14.53 13.66 
VEGF 66.94 27.61 83.35 
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Figure 2D 
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MIP2 100.40 91.49 132.11 
RANTES 21.08 27.17 26.09 
TNFa 7.64 14.53 13.66 
VEGF 66.94 27.61 83.35 
 
Figure 2A and 2B. Influenza virus strain A/PR/8/34 (H1N1) was inactivated using UV treatment 
(for a duration of 45mins). Twenty-four hours after the last exercise session, mice were infected 
via an intranasal route with influenza virus at a dose of 163.84 HA units per mouse (stock virus – 
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HAU= 1024/0.05mL or 10^9.5/mLEID50 diluted 1:6.25 in sterile saline). Viral load was measured 
in the lungs (Figure 2A) and BALF (Figure 2B) using qRT-PCR. Cytokines were measured in 
the BALF at 6 hours (Figure 2C) and 24 hours (Figure 2D) post infection.  
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Table 1A. 
Gene 
Symbol 
Fold change 
(Old EX/Old 
Non-EX) 
P Value 
Bag1 0.82 0.026814   
Cyp1a1 0.32 0.094080   
Cyp2c40 2.39 0.324232   
Dnajb1 1.7 0.044831   
Dnajb5 0.69 0.033988   
Fmo1 0.7 0.044786   
Hopx 0.72 0.018355   
Hspa1a 4.08 0.015297   
Hspa4 0.82 0.083307   
Hspa8 1.31 0.075035   
Hspb2 0.74 0.054431   
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Table 1B 
Gene 
Symbol 
Fold change 
with Age P Value 
Bag1 0.82 0.015410   
Cat 0.7 0.090966   
Cct8 0.84 0.094863   
Clu 1.52 0.064710   
Cyp11a1 7.67 0.168919   
Cyp1a1 2.13 0.148812   
Cyp2f2 0.46 0.010072   
Dnaja1 0.58 0.030747   
Dnaja4 1.25 0.037999   
Dnajb9 0.77 0.002178   
Dnajc9 1.14 0.042118   
Fmo1 0.73 0.020719   
Gpx2 0.7 0.052363   
Hspa1l 0.82 0.028888   
Hspb2 0.75 0.030528   
Serpinh1 0.61 0.005115   
Sod3 0.58 0.007833   
Xdh 2.06 0.019852   
 
Table 1A and 1B: RNA was isolated from non-infected lungs of Old Ex, Old Non-Ex mice and 
Young Non-Ex mice. PCR array for Cellular Stress Responses was used to quantify changes in 
mRNA expression with exercise in aged mice (Table 1A) and with age (Table 1B).  
  
190 
 
ACKNOWLEDGEMENTS 
I would like to express my deepest appreciation and gratitude to my research advisor Dr. 
Marian L. Kohut for her strong support and guidance through this process. I would like to thank 
her for her acceptance of myself into her lab and for her willingness and enthusiasm to mentor 
me through this process. The skill set I have developed while working in her lab, including basic 
experimental design, quality data collection, statistical analysis, and oral and written 
communication, have shown vast improvements because of her support and efforts. In addition, 
her mentorship has been paramount to the success of many of the ideas presented here. Without 
her, this dissertation would have been impossible to complete. 
I would also like to thank my committee members, Dr. Mark Ackermann, Dr. Joan 
Cunnick, Dr. Peter Nara and Dr. Daniel Nettleton for contributing to the development in this 
work. They encouraged me to think and perform better at every step and were always willing and 
accessible to help me through this task. They have provided me with guidance in theory as well 
as practice and I am deeply grateful that they were willing to share their knowledge in their fields 
of expertise and took the time to mentor me when I needed it. Their constructive criticism and 
encouragement improved the quality of this work immensely.  
I would like to thank my lab mates Justus Hallam, Susan Hodgkins and a previous 
member of our lab, Kristi Warren. I am also thankful to all the undergraduate researchers for 
their time and efforts that have contributed in some way to this dissertation. Finally, I would like 
to express my gratitude to my family - my parents Lt Col. Uday Naik and Mrs Ranjana Naik, my 
sister Avani Naik, her husband Anurag Prakash and daughter Zoya, and last but not least my 
191 
 
husband Siddhartha Agrawal. Their countless words of encouragement, unconditional love and 
support helped me through the task of completing this work.    
   
  
 
 
 
 
